General Information of Disease (ID: DISXWP4P)

Disease Name Nephropathy
Synonyms nephropathy; renal disorder; kidney disease or disorder; disease of kidney; kidney disease; disorder of kidney; disease or disorder of kidney; renal disease; kidney disorder
Disease Class GC2Z: Urinary system disease
Definition A disease involving the kidney.
Disease Hierarchy
DIS0HU8N: Urinary tract disease
DISWD40R: Disease
DISXWP4P: Nephropathy
ICD Code
ICD-11
ICD-11: GC2Z
ICD-9
ICD-9: 581.3
Expand ICD-9
581.3
Disease Identifiers
MONDO ID
MONDO_0005240
MESH ID
D007674
UMLS CUI
C0022658
MedGen ID
9635
HPO ID
HP:0000112
SNOMED CT ID
90708001

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 3 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Darbepoetin alfa DMMJTYW Approved NA [1]
Valsartan DMREUQ6 Approved Small molecular drug [2]
Zidovudine DM4KI7O Approved Small molecular drug [3]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 2 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
NCX-4016 DMOX1CU Phase 2 Small molecular drug [4]
ION532 DMC8UPL Phase 1 Antisense oligonucleotide [5]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 253 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
ACACB TTY84UG Limited Genetic Variation [6]
ACKR3 TTRQJTC Limited Biomarker [7]
ATIC TT9NVXQ Limited Biomarker [8]
B2M TTY7FKA Limited Altered Expression [9]
CAD TT2YT1K Limited Biomarker [10]
CELA1 TT3NKIB Limited Biomarker [11]
CFP TTLA0VS Limited Biomarker [12]
CHIT1 TTDYX6T Limited Biomarker [13]
CUL3 TTPCU0Q Limited Biomarker [14]
CYBB TT5T8MR Limited Biomarker [15]
DDR1 TTI1FPZ Limited Biomarker [16]
EHMT1 TTOFXD7 Limited Genetic Variation [17]
EIF2AK3 TT79U1M Limited Biomarker [18]
G6PC TTBQMJ8 Limited Biomarker [19]
GCK TTDLNGZ Limited Biomarker [20]
IFNL1 TTM624L Limited Biomarker [21]
INS TTZOPHG Limited Biomarker [22]
PARP1 TTVDSZ0 Limited Biomarker [23]
PCSK5 TTPFWHU Limited Biomarker [24]
PTGS2 TTVKILB Limited Biomarker [25]
SCGB1A1 TTONPVW Limited Biomarker [26]
SELL TT2IYXF Limited Genetic Variation [27]
SIRT6 TTUXYWF Limited Altered Expression [28]
SOD2 TT9O4C5 Limited Biomarker [29]
TNFRSF1A TTG043C Limited Biomarker [30]
TRPC6 TTRBT3W Limited Altered Expression [31]
UNC13B TT948FC Limited Genetic Variation [32]
VDR TTK59TV Limited Genetic Variation [33]
FCGR2B TT5RWKQ Disputed Genetic Variation [34]
SLC25A4 TTU5A6Q Disputed Genetic Variation [35]
SORD TTLSRBZ Disputed Altered Expression [36]
ADAM17 TT6AZXG moderate Altered Expression [37]
ANGPTL3 TT59GO7 moderate Biomarker [38]
CASP1 TTCQIBE moderate Biomarker [39]
CCR5 TTJIH8Q moderate Genetic Variation [40]
CEP290 TT3XBOV moderate Biomarker [41]
CR2 TT0HUN7 moderate Biomarker [42]
EGF TTED8JB moderate Biomarker [43]
FOSL2 TT689IR moderate Biomarker [44]
FOXC1 TTNT3YA moderate Biomarker [45]
FOXC2 TTLBAP1 moderate Genetic Variation [46]
GDF15 TT4MXVG moderate Biomarker [47]
GLO1 TTV9A7R moderate Genetic Variation [48]
HAMP TTRV5YJ moderate Biomarker [49]
IRS2 TTF95B8 moderate Altered Expression [50]
KLK4 TT4319X moderate Biomarker [51]
MANF TT56RYE moderate Biomarker [52]
MAP3K14 TT4LIAC moderate Biomarker [53]
MAP3K5 TTOQCD8 moderate Biomarker [53]
MBL2 TTMQDZ5 moderate Altered Expression [54]
NPPB TTY63XT moderate Altered Expression [55]
POSTN TT8ALTZ moderate Biomarker [56]
PRMT1 TTVOJAI moderate Biomarker [57]
SLC19A2 TT2A1DZ moderate Biomarker [58]
SLC33A1 TTL69WB moderate Genetic Variation [59]
SPP1 TT8ME6I moderate Genetic Variation [60]
TNFRSF12A TTKPS7V moderate Biomarker [61]
TNFRSF13B TTL9OD4 moderate Genetic Variation [62]
TNFRSF4 TTL31H0 moderate Biomarker [63]
ULK1 TT4D7MJ moderate Biomarker [64]
WNK1 TTJ9UMX moderate Biomarker [65]
ABCC8 TTP835K Strong Altered Expression [66]
ACE2 TTUI5H7 Strong Biomarker [67]
ADAM10 TTVXEGU Strong Altered Expression [68]
ADIPOQ TTXKA7D Strong Biomarker [69]
ADM TTV14YH Strong Biomarker [70]
ADRB2 TTG8ZWP Strong Genetic Variation [71]
AGER TTMO9HF Strong Biomarker [72]
AGRP TT4DE1O Strong Biomarker [73]
AGTR2 TTQVOEI Strong Biomarker [74]
AHSG TTKF4WV Strong Altered Expression [75]
AKR1B1 TTFBNVI Strong Biomarker [76]
ALAD TTJHKYD Strong Biomarker [77]
ALPL TTMR5UV Strong Biomarker [78]
ANGPT1 TTWNQ1T Strong Biomarker [79]
ANXA1 TTUCK4B Strong Altered Expression [80]
APOA1 TT5S8DR Strong Genetic Variation [81]
APOA4 TTNC3WS Strong Biomarker [82]
APOC3 TTXOZQ1 Strong Biomarker [83]
ARG2 TTV1AG6 Strong Biomarker [84]
ARRB1 TTMVD4A Strong Altered Expression [85]
ARSA TTYQANR Strong Genetic Variation [86]
BBOX1 TT9FOLC Strong Altered Expression [87]
BDKRB1 TTG5QIA Strong Biomarker [88]
BGN TT0JPVF Strong Altered Expression [89]
BMP7 TTKOBRA Strong Altered Expression [90]
BTK TTGM6VW Strong Biomarker [91]
C5 TTKANGO Strong Biomarker [92]
CASP3 TTPF2QI Strong Genetic Variation [93]
CASP9 TTB6T7O Strong Biomarker [94]
CCL5 TT9DWLC Strong Altered Expression [95]
CDH5 TTXLCFO Strong Altered Expression [96]
CDKN1A TT9GUW0 Strong Biomarker [97]
CFI TT6ATLX Strong Biomarker [98]
CLCNKB TTR68GQ Strong Genetic Variation [99]
CLU TTRL76H Strong Biomarker [100]
CSF3 TT5TQ2W Strong Therapeutic [101]
CTF1 TTXGTZU Strong Therapeutic [102]
CTNS TT1W2ZS Strong Biomarker [103]
CTSD TTPT2QI Strong Biomarker [104]
CUBN TT9YLCR Strong Genetic Variation [105]
CYP24A1 TT82UI1 Strong Altered Expression [106]
CYP3A4 TTWP7HQ Strong Genetic Variation [107]
CYP3A5 TTHS0OK Strong Genetic Variation [108]
DAO TT7Y3EJ Strong Biomarker [109]
DRD3 TT4C8EA Strong Genetic Variation [110]
DUSP5 TTZN92A Strong Biomarker [111]
EDN1 TTJR60Z Strong Biomarker [112]
EDNRA TTKRD0G Strong Biomarker [7]
ELAVL1 TTPC9D0 Strong Biomarker [113]
ENPP1 TTZTIWS Strong Genetic Variation [114]
EPO TTQG4NR Strong Biomarker [115]
ESRRG TT9ZRHB Strong Biomarker [116]
FABP1 TTIV96N Strong Biomarker [117]
FABP4 TTHWMFZ Strong Biomarker [118]
FGF2 TTGKIED Strong Altered Expression [119]
FGF23 TT2IZ4K Strong Biomarker [120]
FOS TTOM5AU Strong Biomarker [121]
G6PD TTKN8W0 Strong Biomarker [122]
GH1 TTT3YKH Strong Biomarker [123]
GHR TTHJWYD Strong Altered Expression [124]
GLA TTIS03D Strong Genetic Variation [125]
GLP1R TTVIMDE Strong Biomarker [126]
GNAO1 TTAXD8Z Strong Biomarker [127]
GPBAR1 TTSDVTR Strong Altered Expression [128]
GPR182 TTT23CG Strong Biomarker [129]
GSTP1 TT40K12 Strong Biomarker [130]
HCAR2 TTWNV8U Strong Biomarker [131]
HDAC5 TTUELN5 Strong Altered Expression [132]
HLA-DQB2 TTL7VOU Strong Biomarker [127]
HNF1A TT01M3K Strong Biomarker [133]
HNF4A TT2F3CD Strong Genetic Variation [134]
HOXA11 TTEX4ZA Strong Biomarker [135]
HSD11B2 TT9H85R Strong Altered Expression [136]
HSPA9 TTMTPG3 Strong Biomarker [137]
HSPG2 TT5UM29 Strong Genetic Variation [138]
IFNL3 TTRF4Q2 Strong Genetic Variation [139]
IGF1 TTT6LOU Strong Altered Expression [123]
IGFBP7 TTUQ01B Strong Biomarker [140]
IL33 TT5MD4P Strong Biomarker [141]
INPP5D TTTP2Z1 Strong Biomarker [142]
ITGA8 TT1FW8B Strong Genetic Variation [143]
KEAP1 TT3Z6Y9 Strong Biomarker [144]
KLK1 TT5T3P6 Strong Biomarker [145]
KNG1 TTDJ4MY Strong Biomarker [146]
LCN2 TTKTLAI Strong Biomarker [147]
LEPR TT0HD6V Strong Biomarker [148]
LGALS3 TTFPQV7 Strong Biomarker [103]
LPA TTU9LGY Strong Biomarker [149]
LRP2 TTPH1AJ Strong Biomarker [150]
LY96 TT8S9AV Strong Biomarker [151]
LYZ TTAOZBW Strong Biomarker [152]
MASP2 TTR01E9 Strong Biomarker [153]
MIF TT6804T Strong Genetic Variation [154]
MLYCD TT9Z4YD Strong Genetic Variation [155]
MMP7 TTMTWOS Strong Altered Expression [156]
MPO TTVCZPI Strong Biomarker [157]
MUC1 TTBHFYQ Strong Biomarker [158]
NAGLU TTDM6HZ Strong Biomarker [159]
NOS2 TTF10I9 Strong Biomarker [160]
NPR1 TTM9IYA Strong Biomarker [161]
NQO1 TT8XK6L Strong Therapeutic [162]
NR1H4 TTS4UGC Strong Biomarker [128]
NR3C2 TT26PHO Strong Biomarker [163]
PLA2G1B TT9V5JH Strong Biomarker [164]
PLA2R1 TTHKW7D Strong Biomarker [165]
POMC TT21AKM Strong Biomarker [166]
PPARA TTJ584C Strong Genetic Variation [167]
PROC TTZUXYS Strong Biomarker [168]
PSMB8 TTEAD9J Strong Genetic Variation [169]
PTH TT6F7GZ Strong Biomarker [170]
RAC1 TT2M9CG Strong Biomarker [171]
RBP4 TT0C8BY Strong Biomarker [172]
RENBP TTZCG0Q Strong Biomarker [72]
RPS6KA1 TTIXKA4 Strong Biomarker [173]
SCD TT6RIOV Strong Altered Expression [174]
SDC2 TT5H2F0 Strong Genetic Variation [138]
SGK1 TTTV8EJ Strong Biomarker [115]
SIRPA TTBRJS9 Strong Altered Expression [175]
SLC11A2 TT2IS7P Strong Biomarker [176]
SLC12A1 TTS087L Strong Genetic Variation [177]
SLC12A3 TTP362L Strong Genetic Variation [178]
SLC15A2 TT27Q3A Strong Biomarker [179]
SLC17A5 TTFSUIA Strong Biomarker [180]
SLC22A2 TT0XOJN Strong Therapeutic [181]
SLC22A6 TTTYH7A Strong Altered Expression [182]
SLC22A8 TTTQR47 Strong Biomarker [182]
SLC2A9 TTIF3GB Strong Genetic Variation [183]
SLC37A4 TT1KPBZ Strong Biomarker [184]
SLC47A1 TTMHCGA Strong Biomarker [185]
SLC5A1 TT2UE56 Strong Altered Expression [186]
SLC9A3 TTFZVPO Strong Genetic Variation [187]
SMAD7 TT0J32Z Strong Biomarker [188]
SMPD1 TTJTM88 Strong Therapeutic [189]
SPARC TTBQFM7 Strong Biomarker [190]
TERT TTQY2EJ Strong Biomarker [97]
TFAP2A TTDY4BS Strong Biomarker [191]
TGFBR2 TTZE3P7 Strong Biomarker [192]
TMSB4X TTMVAIU Strong Biomarker [193]
TNFSF13 TTOI1RM Strong Biomarker [194]
TNFSF13B TTWMIDN Strong Biomarker [194]
TNFSF4 TTBW580 Strong Biomarker [195]
TREM1 TTHZQP0 Strong Biomarker [196]
TTR TTPOYU7 Strong Biomarker [197]
TXN TTZJ5U9 Strong Biomarker [198]
UTS2 TTERU0T Strong Altered Expression [199]
UTS2R TTW5UDX Strong Genetic Variation [129]
ABCC3 TTVLG21 Definitive ModifyingMutation [200]
ADRA1B TTBRKXS Definitive Biomarker [201]
ANGPT2 TTKLQTJ Definitive Biomarker [202]
AOC3 TT7HC21 Definitive Altered Expression [203]
BLVRA TTJBPN3 Definitive Biomarker [204]
C3AR1 TTI6B3F Definitive Biomarker [205]
CA1 TTHQPL7 Definitive Biomarker [206]
CASP8 TT6SZNG Definitive Biomarker [94]
CETP TTFQAYR Definitive Altered Expression [207]
CFH TTUW6OP Definitive Biomarker [208]
CYP2A6 TTAQ6ZW Definitive Altered Expression [209]
DKK3 TTY2ZV6 Definitive Altered Expression [210]
FABP2 TTS4YLO Definitive Biomarker [211]
FADS2 TTT2VDU Definitive Posttranslational Modification [212]
FAT1 TTGUJYV Definitive Genetic Variation [213]
FGG TTR31L7 Definitive Biomarker [214]
GAD2 TT7UY6K Definitive Genetic Variation [215]
HIPK2 TTOB49C Definitive Biomarker [216]
IFNAR1 TTSYFMA Definitive Biomarker [217]
KIR2DS1 TTVWAGF Definitive Biomarker [218]
LCAT TTGZ91P Definitive Biomarker [219]
LTF TTSZDQU Definitive Biomarker [220]
MKI67 TTB4UNG Definitive Biomarker [221]
MYH2 TTBIL13 Definitive Biomarker [222]
NCF1 TTZ4JC3 Definitive Biomarker [223]
NEK8 TT8AH9I Definitive Biomarker [224]
NFE2L2 TTA6ZN2 Definitive Biomarker [225]
NLRP3 TT4EN8X Definitive Biomarker [226]
NR4A1 TTMXE2Q Definitive Biomarker [227]
PAH TTGSVH2 Definitive Biomarker [228]
PDGFD TTSN0GA Definitive Biomarker [229]
PKD2L1 TTAHD89 Definitive Altered Expression [230]
PLG TTP86E2 Definitive Biomarker [231]
PPP3CA TTA4LDE Definitive Biomarker [232]
PRKCB TTYPXQF Definitive Biomarker [233]
SERPINC1 TT4QPUL Definitive Biomarker [234]
SETD7 TTJ0FSU Definitive Biomarker [235]
SLC19A3 TT9BTWM Definitive Genetic Variation [236]
SREBF1 TTER0UB Definitive Biomarker [237]
SREBF2 TTRQ4AP Definitive Biomarker [237]
STAB1 TTJFEOC Definitive Biomarker [238]
SUCNR1 TT4FX9Y Definitive Biomarker [239]
TGFBR1 TTP4520 Definitive Biomarker [240]
TRPC1 TTA76X0 Definitive Biomarker [241]
TRPC3 TTNVC34 Definitive Biomarker [31]
TRPC5 TT32NQ1 Definitive Biomarker [31]
------------------------------------------------------------------------------------
⏷ Show the Full List of 253 DTT(s)
This Disease Is Related to 7 DTP Molecule(s)
Gene Name DTP ID Evidence Level Mode of Inheritance REF
SLC41A1 DTB37ZE Limited Autosomal recessive [242]
SLC2A2 DTUJPOL moderate Genetic Variation [243]
ABCC11 DTWN7FC Strong Altered Expression [66]
SLC25A16 DTNU9EW Strong Biomarker [244]
SLC7A7 DTE4HJ8 Strong Biomarker [245]
SLC7A9 DTP7AEQ Strong Biomarker [246]
SLC9C1 DT9J8DO Strong Altered Expression [247]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 DTP(s)
This Disease Is Related to 7 DME Molecule(s)
Gene Name DME ID Evidence Level Mode of Inheritance REF
ABO DESIA7R Strong Biomarker [248]
CYP2C8 DES5XRU Strong Genetic Variation [249]
DDAH1 DEY0TQC Strong Biomarker [250]
NAT8 DEA742Z Definitive Genetic Variation [251]
PON2 DEHJU7E Definitive Genetic Variation [252]
SULT1E1 DESTKG6 Definitive Biomarker [253]
UGT2B17 DEAZDL8 Definitive Genetic Variation [254]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 DME(s)
This Disease Is Related to 297 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
CCT2 OTW1VV4E Limited Biomarker [255]
CD151 OTF3UZS7 Limited Genetic Variation [256]
CELA3A OT9JAL80 Limited Biomarker [11]
CFHR1 OT72R16T Limited Biomarker [257]
CFHR3 OTYL8SDO Limited Biomarker [258]
CSH1 OT33HTRR Limited Biomarker [259]
CSH2 OTW8JVAN Limited Biomarker [259]
DIAPH1 OTZBYPLH Limited Biomarker [260]
EFNB2 OT0DCUOM Limited Biomarker [261]
ERCC8 OT0T4WKI Limited Biomarker [259]
HAS2 OTTD3PAL Limited Genetic Variation [262]
HAS3 OTPM8IL8 Limited Genetic Variation [262]
IFT140 OT6KO5FH Limited Genetic Variation [263]
IL17C OTKXIVNQ Limited Biomarker [264]
IL17RE OTMFTNLS Limited Biomarker [264]
INVS OT8KPESR Limited Biomarker [265]
KCNE1 OTZNQUW9 Limited Genetic Variation [266]
MCF2L2 OTOGFMIH Limited Genetic Variation [267]
NSA2 OTRU5QPO Limited Altered Expression [268]
PCBD1 OTDSRUD5 Limited Genetic Variation [269]
RETN OTW5Z1NH Limited Biomarker [270]
SLC41A1 OT4QBRK3 Limited Autosomal recessive [242]
SNRPD1 OTWKZV4E Limited Biomarker [271]
SP3 OTYDQZ1T Limited Genetic Variation [272]
THG1L OTUK054V Limited Biomarker [45]
TMEM67 OTME92T5 Limited Genetic Variation [273]
CADM1 OTRWG9QS Disputed Biomarker [274]
CLC OTYMYR85 Disputed Altered Expression [275]
DST OTHZBM4X Disputed Biomarker [276]
FCGR2C OTNLMNYB Disputed Genetic Variation [34]
FMOD OT9EJ5H8 Disputed Biomarker [277]
GNB3 OTA6HYBA Disputed Genetic Variation [278]
LDB1 OT20EAPR Disputed Genetic Variation [279]
MINDY4 OTBZ2SZB Disputed Altered Expression [280]
NR2E1 OTW47GKM Disputed Genetic Variation [281]
NXPH1 OTGKX860 Disputed Genetic Variation [282]
RAB4A OT7BL9WW Disputed Genetic Variation [283]
SACM1L OT6ORKTD Disputed Genetic Variation [284]
TESC OTI8C76M Disputed Biomarker [285]
ABCG8 OTIJ76XW moderate Genetic Variation [286]
APOL4 OTTOH86V moderate Genetic Variation [287]
AQP11 OT1IQMHV moderate Genetic Variation [288]
C1QTNF1 OT7I7KHC moderate Altered Expression [289]
CARS1 OTOUZF6O moderate Genetic Variation [290]
CHMP2B OTZA7RJB moderate Biomarker [176]
CRELD2 OTL73AO8 moderate Biomarker [52]
CYGB OTX153DQ moderate Biomarker [291]
DMRT1 OT5PU9U1 moderate Biomarker [176]
FLII OT7G9JG6 moderate Biomarker [292]
FOXD3 OTXYV6GO moderate Biomarker [293]
FRMD3 OT0CD2GG moderate Genetic Variation [294]
GFPT1 OTQBDO45 moderate Altered Expression [295]
GPRC5B OTF3S5E3 moderate Altered Expression [296]
IQCB1 OTYQ28V9 moderate Genetic Variation [297]
KIR3DS1 OTJWIO4T moderate Biomarker [298]
KLF15 OTGMQMVR moderate Biomarker [299]
MGP OTZWU3FU moderate Genetic Variation [300]
MYO16 OTMS3D8W moderate Genetic Variation [290]
NPHP1 OTZHCFFQ moderate Genetic Variation [282]
PAX2 OTKP1N8F moderate Biomarker [301]
RPGRIP1L OT6Z069I moderate Biomarker [302]
SCARB2 OTN929M8 moderate Genetic Variation [303]
SCNN1A OTE2KVZV moderate Biomarker [304]
SCNN1G OTSJYQVQ moderate Genetic Variation [305]
SPESP1 OTWXKKTJ moderate Biomarker [306]
TTC21B OTXXA87U moderate Genetic Variation [307]
ACSL1 OTB06ESI Strong Altered Expression [308]
ACTA2 OTEDLG8E Strong Biomarker [309]
ACTN4 OTCNZAJ5 Strong Biomarker [310]
ADAM19 OTH88TXU Strong Biomarker [311]
ADD1 OTTF68DC Strong Genetic Variation [312]
AGXT2 OTO6QUTM Strong Genetic Variation [313]
AHI1 OT8K2YWY Strong Genetic Variation [314]
AMBP OTLU8GU8 Strong Altered Expression [315]
ANLN OTXJY54C Strong Altered Expression [316]
ANP32B OT3SQMLU Strong Biomarker [194]
AP3B1 OTYTIH5Q Strong Biomarker [317]
APOC1 OTA58CED Strong Genetic Variation [318]
APOM OTI3FQQC Strong Biomarker [319]
AQP2 OTQLBKK6 Strong Altered Expression [320]
AQP6 OTXS6UYY Strong Biomarker [321]
ARSL OTF1VTCR Strong Biomarker [322]
ARTN OTWIWGL6 Strong Biomarker [73]
ATP6 OTPHOGLX Strong Genetic Variation [323]
ATP6AP2 OT0IABVV Strong Biomarker [324]
BBS7 OTELYWDQ Strong Genetic Variation [325]
BHLHE41 OTY9GJ1Y Strong Biomarker [326]
BICC1 OTYRKIJ1 Strong Genetic Variation [327]
C1GALT1 OT2ZSZ6P Strong Biomarker [328]
CABIN1 OT4G5CIK Strong Biomarker [329]
CALB1 OTM7IXDG Strong Biomarker [330]
CALD1 OTNJKJ6Q Strong Biomarker [331]
CAMK4 OT47RDGV Strong Biomarker [332]
CAPN9 OTE4IU5U Strong Biomarker [333]
CAV2 OT1FGRQX Strong Biomarker [334]
CCHCR1 OT22C116 Strong Genetic Variation [335]
CCN3 OTOW5YL4 Strong Altered Expression [336]
CD2AP OTC76KQM Strong Genetic Variation [337]
CLCN5 OT9YXZSO Strong Altered Expression [338]
CLDN16 OTTHAIKR Strong Biomarker [339]
CMIP OTZN8Z4A Strong Altered Expression [340]
CNDP1 OTOYSQG7 Strong Biomarker [341]
CNNM2 OTZHO8WU Strong Biomarker [342]
CNTN3 OTC1274J Strong Genetic Variation [343]
COL4A4 OT9G0MCT Strong Genetic Variation [344]
COLEC11 OT4GC46Y Strong Biomarker [345]
COQ2 OTDAKEY4 Strong Biomarker [346]
COQ8B OTBY50BD Strong Genetic Variation [347]
CST3 OTNZ6AO4 Strong Biomarker [348]
CYBA OT16N9ZO Strong Genetic Variation [349]
DAB2 OTRMQTMZ Strong Biomarker [350]
DERL2 OTI3TUUZ Strong Biomarker [351]
EFNB1 OT7JJW8P Strong Biomarker [352]
ELMO1 OTY2ORXK Strong Genetic Variation [178]
ERAL1 OTSH78HD Strong Genetic Variation [353]
FAM20A OT5Z5IW8 Strong Genetic Variation [354]
FAR2 OTRYY709 Strong Biomarker [355]
FGA OTMIHY80 Strong Biomarker [356]
FGL1 OTT0QHQ1 Strong Biomarker [317]
FLI1 OT0EV3LX Strong Biomarker [357]
GABPA OT9YB2SA Strong Biomarker [225]
GADD45G OT8V1J4M Strong Altered Expression [358]
GATM OTIJ4Z11 Strong Biomarker [172]
GDF11 OTOSNMND Strong Biomarker [359]
GLIS2 OTOUUV1X Strong Genetic Variation [360]
GNMT OT0O2OQO Strong Biomarker [361]
GOLGA6A OTHU9MRX Strong Genetic Variation [362]
GPX3 OT6PK94R Strong Altered Expression [363]
GUCA2A OTUSF75G Strong Biomarker [364]
GUCA2B OTZERX04 Strong Biomarker [364]
HAP1 OT6SG0JQ Strong Altered Expression [365]
HAVCR1 OT184CRZ Strong Biomarker [366]
HBA1 OTW2BQF4 Strong Biomarker [367]
HLA-DPA1 OT7OG7Y2 Strong Biomarker [328]
HLA-E OTX1CTFB Strong Genetic Variation [368]
HORMAD2 OTL2ENWI Strong Genetic Variation [169]
HOXD11 OT9XGA4G Strong Biomarker [135]
HPS1 OTKS5I7T Strong Biomarker [317]
IFT122 OTSK3OAD Strong Biomarker [369]
JADE1 OTBPJIRI Strong Altered Expression [370]
LAMA5 OTIIXE4M Strong Genetic Variation [371]
LECT2 OTSFZ9JD Strong Biomarker [372]
LIPC OTZY5SC9 Strong Genetic Variation [373]
LRSAM1 OTOKWR6C Strong Biomarker [374]
MAGED2 OTMEWNSE Strong Biomarker [375]
MAGI2 OTXDDKZS Strong Altered Expression [376]
MCU OTQZAYWQ Strong Biomarker [377]
MDH2 OT7364GY Strong Biomarker [378]
MEFV OTRJ6S6K Strong Biomarker [379]
MKKS OTLF5T11 Strong Genetic Variation [302]
MKS1 OT83W5PB Strong Genetic Variation [302]
MLN OTBZ5SE5 Strong Biomarker [380]
MMD OTB5I4OC Strong Biomarker [381]
MOCOS OT0TL3Q5 Strong Biomarker [382]
MOK OTQK7M9V Strong Biomarker [72]
MPV17 OT579DMU Strong Biomarker [383]
MT4 OTDBOZEN Strong Biomarker [384]
MXI1 OTUQ9E0D Strong Biomarker [385]
MYBPH OTQJBPUR Strong Biomarker [386]
MYO1E OTM9YSIZ Strong Genetic Variation [387]
MYOCD OTSJNHTH Strong Altered Expression [388]
NBAS OTW9IBRI Strong Biomarker [159]
NCF2 OTAUW7L2 Strong Biomarker [389]
ND5 OT45LW1K Strong Genetic Variation [390]
NEDD4L OT1B19RU Strong Biomarker [391]
NFYA OTWFFOVH Strong Altered Expression [365]
NOX1 OTZPJQCC Strong Altered Expression [392]
NOX5 OTHTH59G Strong Altered Expression [393]
NPHP4 OTBNOA7U Strong Genetic Variation [394]
NPHS1 OT21JD3P Strong Genetic Variation [395]
NPHS2 OTLCNUII Strong Biomarker [64]
NRK OTGR01FF Strong Biomarker [396]
NT5C1A OTS7UF36 Strong Genetic Variation [397]
OGA OT7ZBWT1 Strong Altered Expression [398]
PALD1 OTLGUM8H Strong Altered Expression [399]
PALLD OTZ2MUJZ Strong Altered Expression [399]
PC OT6O0V51 Strong Altered Expression [400]
PDSS2 OTEOQBMX Strong Biomarker [401]
PGLYRP1 OTBTPR2T Strong Biomarker [402]
PHB2 OTCAX3AW Strong Biomarker [403]
PKD1 OT5ALRZ5 Strong Biomarker [404]
PKD2 OTIXBU8H Strong Genetic Variation [405]
PLXNA1 OTN0BING Strong Biomarker [406]
PODXL OTPNQXF3 Strong Biomarker [407]
PSMA6 OTJ6RPX5 Strong Biomarker [408]
PSMD9 OT6Y5CC3 Strong Genetic Variation [409]
PYCARD OT67RON3 Strong Biomarker [39]
RAMP2 OTGQXLH5 Strong Biomarker [410]
RAPGEF5 OT53VS75 Strong Biomarker [411]
RASAL1 OTAHUNN7 Strong Biomarker [412]
RCAN1 OT1MVXC7 Strong Altered Expression [413]
RCBTB1 OTAYELI8 Strong Genetic Variation [362]
RFC1 OT3L5PK3 Strong Biomarker [414]
RGCC OTYJMLWM Strong Biomarker [415]
RGN OTD04KB1 Strong Biomarker [416]
RPL10 OTBHOZGC Strong Biomarker [406]
RPL17 OTTYMPS6 Strong Genetic Variation [417]
RPS19 OTBKGP48 Strong Biomarker [418]
RRM2B OTE8GBUR Strong Biomarker [419]
RSAD2 OTCA9WCM Strong Biomarker [321]
RSC1A1 OT54EM29 Strong Biomarker [420]
RUVBL1 OTWV19L7 Strong Biomarker [421]
SCN7A OTK05PXY Strong Biomarker [159]
SDC4 OTKUVUGZ Strong Biomarker [422]
SDCCAG8 OTV2ZGV9 Strong Biomarker [423]
SIGLEC1 OTNWSQA9 Strong Biomarker [424]
SIX2 OTYOVGSC Strong Biomarker [425]
SMARCAL1 OTTKXLUZ Strong Genetic Variation [426]
SMCP OTXKY794 Strong Biomarker [382]
SNX9 OTLNQ0ZM Strong Altered Expression [427]
SOSTDC1 OTAKDNSM Strong Biomarker [428]
SPATA2 OTOA45GL Strong Genetic Variation [417]
SSBP1 OTH2PZWH Strong Biomarker [429]
STX2 OTO2IDDR Strong Biomarker [430]
SUMO4 OT9B447E Strong Genetic Variation [431]
SV2B OTAO5WIU Strong Altered Expression [432]
SYNPO OTICDJAB Strong Biomarker [433]
TAS2R13 OTSTOX5G Strong Genetic Variation [434]
TBX18 OT3BEBLN Strong Altered Expression [435]
TBX3 OTM64N7K Strong Biomarker [436]
TFF3 OTJJDRTU Strong Biomarker [100]
TGFBI OTR443C5 Strong Biomarker [437]
THSD7A OT7249HH Strong Biomarker [165]
TM7SF2 OTILU5S7 Strong Biomarker [79]
TP53INP2 OT0GTBXO Strong Altered Expression [438]
TRAP1 OTNG0L8J Strong Biomarker [45]
TREH OTJE0NOY Strong Altered Expression [439]
TREX1 OTQG7K12 Strong Genetic Variation [440]
TRIB3 OTG5OS7X Strong Genetic Variation [434]
ADD3 OTDRSHAZ Definitive Biomarker [441]
ALPK1 OTBW6SGD Definitive Biomarker [95]
ANKS1B OT26DGM9 Definitive Genetic Variation [442]
AQP5 OT77GBY8 Definitive Biomarker [443]
ARF6 OTVV7KJO Definitive Biomarker [444]
ARHGEF11 OTDOMEH6 Definitive Genetic Variation [445]
ARID2 OTIRJXWM Definitive Biomarker [446]
BBS12 OT43DTAV Definitive Biomarker [447]
C1GALT1C1 OTRTZUF5 Definitive Biomarker [448]
CCL28 OTY6XNQ7 Definitive Genetic Variation [449]
CD5L OTPY4WQR Definitive Altered Expression [450]
CEP97 OTX7ELQ0 Definitive Biomarker [451]
CLDN19 OTVD6IBL Definitive Genetic Variation [452]
CLEC4E OT7P8ICY Definitive Biomarker [453]
CNDP2 OTJR9436 Definitive Biomarker [454]
COL4A2 OTJK1LKN Definitive Genetic Variation [455]
COMMD5 OT6R7DXN Definitive Biomarker [456]
CORO2B OTCJG5WM Definitive Altered Expression [457]
COX3 OTNNGBYJ Definitive Genetic Variation [458]
COX7A2L OTY21FKV Definitive Genetic Variation [442]
CRB2 OTG0L2CE Definitive Genetic Variation [459]
DDAH2 OT8Q40G2 Definitive Biomarker [460]
DDN OTM52ZF5 Definitive Biomarker [461]
DDOST OT39PDMS Definitive Biomarker [462]
DECR1 OTCDIR6X Definitive Altered Expression [463]
DNASE2 OT6RC1BL Definitive Genetic Variation [464]
EDA OTAKS5WS Definitive Biomarker [465]
EFHD2 OTM9VMN3 Definitive Altered Expression [466]
ELOVL5 OT375W1Z Definitive Posttranslational Modification [212]
EPB41L5 OTPPQPLU Definitive Biomarker [467]
ETFA OTXX61VZ Definitive Genetic Variation [468]
EYA1 OTHU807A Definitive Genetic Variation [469]
FBLIM1 OTFHXMON Definitive Biomarker [470]
FERMT2 OTZNPWWX Definitive Biomarker [471]
GAS1 OTKJXG52 Definitive Genetic Variation [401]
GCKR OTSIWXGG Definitive Genetic Variation [472]
GOLGB1 OT2S0GK8 Definitive Biomarker [473]
GOPC OTRBGH71 Definitive Biomarker [470]
HHIP OT77RQYS Definitive Altered Expression [474]
HMCN1 OTLZAS0P Definitive Biomarker [475]
INHBC OT8SUTZR Definitive Genetic Variation [476]
ITPKC OT73T6T6 Definitive Genetic Variation [477]
KCNK5 OT68V64E Definitive Genetic Variation [478]
KIR2DS3 OT3PSLDL Definitive Biomarker [218]
LAMB2 OT71OI2Y Definitive Genetic Variation [479]
LIMS1 OT729S0T Definitive Biomarker [480]
MAPRE1 OTCVQD60 Definitive Genetic Variation [442]
MAPRE2 OTAE3MX4 Definitive Genetic Variation [442]
MTHFS OTZ39JNR Definitive Biomarker [481]
NOSIP OTQTNFPJ Definitive Biomarker [220]
NPS OTEG25A2 Definitive Genetic Variation [482]
OR10A4 OTYYB8SY Definitive Genetic Variation [483]
PROZ OTI3TXBE Definitive Altered Expression [484]
PSD4 OTEFB87Z Definitive Genetic Variation [485]
RELB OTU3QYEF Definitive Biomarker [221]
RNLS OTVP2WJM Definitive Biomarker [486]
RTN1 OTCX1SMK Definitive Biomarker [487]
SALL1 OTYYZGLH Definitive Genetic Variation [488]
SEMA3G OTBLVF8V Definitive Biomarker [489]
SGF29 OTTE5GOJ Definitive Genetic Variation [490]
SH2B2 OTEDHHDH Definitive Biomarker [491]
SMPDL3B OTZ3KNFJ Definitive Altered Expression [492]
SMURF2 OT3TRVL7 Definitive Altered Expression [493]
SOD3 OTIOZQAB Definitive Biomarker [494]
SORCS1 OTP8PAKU Definitive Genetic Variation [495]
SRL OT7IEBWZ Definitive Biomarker [496]
STATH OTQHBHM9 Definitive Genetic Variation [442]
TNMD OTHLVA9G Definitive Biomarker [497]
------------------------------------------------------------------------------------
⏷ Show the Full List of 297 DOT(s)

References

1 Initial responsiveness to darbepoetin alfa and its contributing factors in non-dialysis chronic kidney disease patients in Japan. Clin Exp Nephrol. 2021 Feb;25(2):110-119.
2 Valsartan FDA Label
3 Zidovudine FDA Label
4 Emerging drugs in peripheral arterial disease. Expert Opin Emerg Drugs. 2006 Mar;11(1):75-90.
5 ClinicalTrials.gov (NCT04269031) A Phase I, First-in-Human, Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD2373 Following Single Ascending Dose Administrations to Healthy Male Subjects of African Ancestry. U.S.National Institutes of Health.
6 The association between lipid metabolism gene polymorphisms and nephropathy in type 2 diabetes: a meta-analysis.Int Urol Nephrol. 2015 Jan;47(1):117-30. doi: 10.1007/s11255-014-0843-6. Epub 2014 Sep 28.
7 Bile Acid G Protein-Coupled Membrane Receptor TGR5 Modulates Aquaporin 2-Mediated Water Homeostasis.J Am Soc Nephrol. 2018 Nov;29(11):2658-2670. doi: 10.1681/ASN.2018030271. Epub 2018 Oct 10.
8 Novel protective mechanism of reducing renal cell damage in diabetes: Activation AMPK by AICAR increased NRF2/OGG1 proteins and reduced oxidative DNA damage.Cell Cycle. 2016 Nov 16;15(22):3048-3059. doi: 10.1080/15384101.2016.1231259. Epub 2016 Sep 9.
9 Effect factors related to a high probability of hemodialysis independence in newly diagnosed multiple myeloma patients requiring hemodialysis.J Clin Lab Anal. 2020 Feb;34(2):e23057. doi: 10.1002/jcla.23057. Epub 2019 Oct 30.
10 Carotid intima-media thickness values are significantly higher in patients with prediabetes compared to normal glucose metabolism.Medicine (Baltimore). 2019 Nov;98(44):e17805. doi: 10.1097/MD.0000000000017805.
11 Exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1-associated renal disease and can be symptomatic.Clin Kidney J. 2018 Aug;11(4):453-458. doi: 10.1093/ckj/sfx150. Epub 2018 Jan 30.
12 The role of properdin in complement-mediated renal diseases: a new player in complement-inhibiting therapy?.Pediatr Nephrol. 2019 Aug;34(8):1349-1367. doi: 10.1007/s00467-018-4042-z. Epub 2018 Aug 23.
13 Association of chitotriosidase enzyme activity and genotype with the risk of nephropathy in type 2 diabetes.Clin Biochem. 2016 Apr;49(6):444-448. doi: 10.1016/j.clinbiochem.2015.11.009. Epub 2015 Nov 14.
14 Disruption of CUL3-mediated ubiquitination causes proximal tubule injury and kidney fibrosis.Sci Rep. 2019 Mar 14;9(1):4596. doi: 10.1038/s41598-019-40795-0.
15 Sex-specific associations of variants in regulatory regions of NADPH oxidase-2 (CYBB) and glutathione peroxidase 4 (GPX4) genes with kidney disease in type 1 diabetes.Free Radic Res. 2013 Oct;47(10):804-10. doi: 10.3109/10715762.2013.828347. Epub 2013 Aug 19.
16 Discoidin Domain Receptor 1 (DDR1) tyrosine kinase is upregulated in PKD kidneys but does not play a role in the pathogenesis of polycystic kidney disease.PLoS One. 2019 Jul 1;14(7):e0211670. doi: 10.1371/journal.pone.0211670. eCollection 2019.
17 Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus.Circulation. 2019 Apr 23;139(17):2022-2031. doi: 10.1161/CIRCULATIONAHA.118.038868.
18 Activation of PERK-eIF2-ATF4-CHOP axis triggered by excessive ER stress contributes to lead-induced nephrotoxicity.Biochim Biophys Acta Mol Cell Res. 2019 Apr;1866(4):713-726. doi: 10.1016/j.bbamcr.2018.12.002. Epub 2018 Dec 4.
19 Tight metabolic control plus ACE inhibitor therapy improves GSD I nephropathy.J Inherit Metab Dis. 2017 Sep;40(5):703-708. doi: 10.1007/s10545-017-0054-2. Epub 2017 Jun 13.
20 Long-term renal changes in the liver-specific glucokinase knockout mouse: implications for renal disease in maturity-onset diabetes of the young 2.Transl Res. 2011 Mar;157(3):111-6. doi: 10.1016/j.trsl.2010.11.003. Epub 2010 Dec 13.
21 Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity.Arthritis Res Ther. 2011 Jun 16;13(3):R88. doi: 10.1186/ar3363.
22 Shortened telomere length in white blood cells of patients with IDDM.Diabetes. 1998 Mar;47(3):482-6. doi: 10.2337/diabetes.47.3.482.
23 PARP inhibition ameliorates nephropathy in an animal model of type 2 diabetes: focus on oxidative stress, inflammation, and fibrosis.Naunyn Schmiedebergs Arch Pharmacol. 2017 Jun;390(6):621-631. doi: 10.1007/s00210-017-1360-9. Epub 2017 Feb 21.
24 VACTERL/caudal regression/Currarino syndrome-like malformations in mice with mutation in the proprotein convertase Pcsk5.Genes Dev. 2008 Jun 1;22(11):1465-77. doi: 10.1101/gad.479408.
25 Differential compensation of two cyclooxygenases in renal homeostasis is independent of prostaglandin-synthetic capacity under basal conditions.FASEB J. 2018 Oct;32(10):5326-5337. doi: 10.1096/fj.201800252R. Epub 2018 Apr 20.
26 Urine proteome analysis by C18 plate-matrix-assisted laser desorption/ionization time-of-flight mass spectrometry allows noninvasive differential diagnosis and prediction of diabetic nephropathy.PLoS One. 2018 Jul 19;13(7):e0200945. doi: 10.1371/journal.pone.0200945. eCollection 2018.
27 l-selectin gene polymorphisms and complications of sickle cell disease.Int J Lab Hematol. 2008 Aug;30(4):312-6. doi: 10.1111/j.1751-553X.2007.00961.x.
28 The deacetylase sirtuin 6 protects against kidneyfibrosis by epigenetically blocking -catenin targetgene expression.Kidney Int. 2020 Jan;97(1):106-118. doi: 10.1016/j.kint.2019.08.028. Epub 2019 Sep 17.
29 MnTBAP therapy attenuates the downregulation of sodium transporters in obstructive kidney disease.Oncotarget. 2017 Dec 7;9(1):394-403. doi: 10.18632/oncotarget.23037. eCollection 2018 Jan 2.
30 Circulating TNF receptors and risk of renal disease progression, cardiovascular disease events and mortality in patients with diabetes: a systematic review and meta-analysis.Endocrine. 2020 Apr;68(1):32-43. doi: 10.1007/s12020-019-02153-y. Epub 2019 Dec 7.
31 TRPC channels: Regulation, dysregulation and contributions to chronic kidney disease.Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1041-1066. doi: 10.1016/j.bbadis.2019.04.001. Epub 2019 Apr 4.
32 G/T substitution in intron 1 of the UNC13B gene is associated with increased risk of nephropathy in patients with type 1 diabetes.Diabetes. 2008 Oct;57(10):2843-50. doi: 10.2337/db08-0073. Epub 2008 Jul 15.
33 Association of vitamin D receptor TaqI and ApaI genetic polymorphisms with nephrolithiasis and end stage renal disease: a meta-analysis.BMC Med Genet. 2019 Dec 10;20(1):193. doi: 10.1186/s12881-019-0932-6.
34 Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients.Arthritis Rheum. 1995 Dec;38(12):1832-6. doi: 10.1002/art.1780381217.
35 Mouse models for mitochondrial disease.Am J Med Genet. 2001 Spring;106(1):71-93. doi: 10.1002/ajmg.1393.
36 Aldose reductase expression is induced by hyperglycemia in diabetic nephropathy.Kidney Int. 2001 Jul;60(1):211-8. doi: 10.1046/j.1523-1755.2001.00788.x.
37 Role of ADAM17 in kidney disease.Am J Physiol Renal Physiol. 2019 Aug 1;317(2):F333-F342. doi: 10.1152/ajprenal.00625.2018. Epub 2019 May 29.
38 Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss.BMC Nephrol. 2019 May 24;20(1):185. doi: 10.1186/s12882-019-1383-1.
39 Multifactorial functions of the inflammasome component NLRP3 in pathogenesis of chronic kidney diseases.Kidney Int. 2019 Jul;96(1):58-66. doi: 10.1016/j.kint.2019.01.014. Epub 2019 Mar 4.
40 Variations in CCR5, but not HFE, ELMO1, or SLC12A3, are associated with susceptibility to kidney disease in north Indian individuals with type 2 diabetes.J Diabetes. 2014 Nov;6(6):547-55. doi: 10.1111/1753-0407.12128. Epub 2014 Feb 25.
41 A human patient-derived cellular model of Joubert syndrome reveals ciliary defects which can be rescued with targeted therapies.Hum Mol Genet. 2017 Dec 1;26(23):4657-4667. doi: 10.1093/hmg/ddx347.
42 Targeting the Immune Complex-Bound Complement C3d Ligand as a Novel Therapy for Lupus.J Immunol. 2019 Dec 15;203(12):3136-3147. doi: 10.4049/jimmunol.1900620. Epub 2019 Nov 15.
43 Targeting CTGF, EGF and PDGF pathways to prevent progression of kidney disease.Nat Rev Nephrol. 2014 Dec;10(12):700-11. doi: 10.1038/nrneph.2014.184. Epub 2014 Oct 14.
44 Fra-2 is a novel candidate drug target expressed in the podocytes of lupus nephritis.Clin Immunol. 2018 Dec;197:179-185. doi: 10.1016/j.clim.2018.10.001. Epub 2018 Oct 5.
45 Profibrotic IHG-1 complexes with renal disease associated HSPA5 and TRAP1 in mitochondria.Biochim Biophys Acta Mol Basis Dis. 2017 Apr;1863(4):896-906. doi: 10.1016/j.bbadis.2017.01.015. Epub 2017 Jan 20.
46 A novel frameshift mutation of FOXC2 gene in a family with hereditary lymphedema-distichiasis syndrome associated with renal disease and diabetes mellitus.Am J Med Genet A. 2004 Dec 15;131(3):281-6. doi: 10.1002/ajmg.a.30390.
47 The clinical impact of growth differentiation factor-15 in heart disease: A 2019 update.Crit Rev Clin Lab Sci. 2020 Mar;57(2):114-125. doi: 10.1080/10408363.2019.1678565. Epub 2019 Oct 30.
48 Association of two glyoxalase I gene polymorphisms with nephropathy and retinopathy in Type 2 diabetes.J Endocrinol Invest. 2011 Nov;34(10):e343-8. doi: 10.3275/7856. Epub 2011 Jul 7.
49 Hepcidin and arterial stiffness in children with systemic lupus erythematosus and lupus nephritis: A cross-sectional study.PLoS One. 2019 Mar 29;14(3):e0214248. doi: 10.1371/journal.pone.0214248. eCollection 2019.
50 Insulin Receptor Substrate 2 mRNA Expression in Urinary Sediment Cells as a Diagnostic Marker of Nephropathy in Diabetic Patients.Iran J Kidney Dis. 2018 May;12(3):142-149.
51 Cardiovascular properties of the kallikrein-kinin system.Curr Med Res Opin. 2002;18(1):10-7. doi: 10.1185/03007990212500093.
52 Endoplasmic reticulum stress and monogenic kidney diseases in precision nephrology.Pediatr Nephrol. 2019 Sep;34(9):1493-1500. doi: 10.1007/s00467-018-4031-2. Epub 2018 Aug 11.
53 MAP3K kinases and kidney injury.Nefrologia (Engl Ed). 2019 Nov-Dec;39(6):568-580. doi: 10.1016/j.nefro.2019.03.004. Epub 2019 Jun 10.
54 Mannose-Binding Lectin Levels in Critically Ill Children With Severe Infections.Pediatr Crit Care Med. 2017 Feb;18(2):103-111. doi: 10.1097/PCC.0000000000001000.
55 N-terminal pro-brain natriuretic peptide levels predict left ventricular systolic function in patients with chronic kidney disease.J Korean Med Sci. 2009 Jan;24 Suppl(Suppl 1):S63-8. doi: 10.3346/jkms.2009.24.S1.S63. Epub 2009 Jan 28.
56 Assessment of two novel renal tubular proteins in type 2 diabetic patients with nephropathy.J Investig Med. 2020 Mar;68(3):748-755. doi: 10.1136/jim-2019-001135. Epub 2019 Nov 12.
57 Protein arginine methyltransferase 1 mediates renal fibroblast activation and fibrogenesis through activation of Smad3 signaling.Am J Physiol Renal Physiol. 2020 Feb 1;318(2):F375-F387. doi: 10.1152/ajprenal.00487.2019. Epub 2019 Dec 9.
58 Variation in SLC19A3 and Protection From Microvascular Damage in Type 1 Diabetes.Diabetes. 2016 Apr;65(4):1022-30. doi: 10.2337/db15-1247. Epub 2015 Dec 30.
59 Future drug discovery in renin-angiotensin-aldosterone system intervention.Expert Opin Drug Discov. 2017 Aug;12(8):827-848. doi: 10.1080/17460441.2017.1335301. Epub 2017 Jun 9.
60 The role of osteopontin in kidney diseases.Inflamm Res. 2019 Feb;68(2):93-102. doi: 10.1007/s00011-018-1200-5. Epub 2018 Nov 19.
61 Biomeasures and mechanistic modeling highlight PK/PD risks for a monoclonal antibody targeting Fn14 in kidney disease.MAbs. 2018 Jan;10(1):62-70. doi: 10.1080/19420862.2017.1398873. Epub 2017 Nov 30.
62 TACI deletion protects against progressive murine lupus nephritis induced by BAFF overexpression.Kidney Int. 2018 Oct;94(4):728-740. doi: 10.1016/j.kint.2018.03.012. Epub 2018 Jun 12.
63 The Ox40/Ox40 Ligand Pathway Promotes Pathogenic Th Cell Responses, Plasmablast Accumulation, and Lupus Nephritis in NZB/W F1 Mice.J Immunol. 2017 Aug 15;199(4):1238-1249. doi: 10.4049/jimmunol.1700608. Epub 2017 Jul 10.
64 Epidermal growth factor receptor and podocin predict nephropathy progression in type 2 diabetic patients through interaction with the autophagy influencer ULK-1.J Diabetes Complications. 2019 Feb;33(2):128-133. doi: 10.1016/j.jdiacomp.2018.11.007. Epub 2018 Nov 22.
65 MiR-373 exacerbates renal injury and fibrosis via NF-B/MatrixMetalloproteinase-9 signaling by targeting Sirtuin1.Genomics. 2019 Jul;111(4):786-792. doi: 10.1016/j.ygeno.2018.04.017. Epub 2018 May 1.
66 Predictive significance of kidney myeloid-related protein 8 expression in patients with obesity- or type 2 diabetes-associated kidney diseases.PLoS One. 2014 Feb 18;9(2):e88942. doi: 10.1371/journal.pone.0088942. eCollection 2014.
67 Angiotensin-converting enzyme 2 and renal disease.Curr Opin Nephrol Hypertens. 2018 Jan;27(1):35-41. doi: 10.1097/MNH.0000000000000378.
68 Renal ADAM10 and 17: Their Physiological and Medical Meanings.Front Cell Dev Biol. 2018 Nov 6;6:153. doi: 10.3389/fcell.2018.00153. eCollection 2018.
69 Adiponectin and Its Isoforms in Pathophysiology.Adv Clin Chem. 2018;85:115-147. doi: 10.1016/bs.acc.2018.02.007. Epub 2018 Mar 14.
70 Adrenomedullin ameliorates podocyte injury induced by puromycin aminonucleoside in vitro and in vivo through modulation of Rho GTPases.Int Urol Nephrol. 2017 Aug;49(8):1489-1506. doi: 10.1007/s11255-017-1622-y. Epub 2017 May 20.
71 Association of the ADRB2 (rs2053044) polymorphism and angiotensin-converting enzyme-inhibitor blood pressure response in the African American Study of Kidney Disease and Hypertension.Pharmacogenet Genomics. 2015 Sep;25(9):444-9. doi: 10.1097/FPC.0000000000000154.
72 Receptor for Advanced Glycation End Products Antagonism Blunts Kidney Damage in Transgenic Townes Sickle Mice.Front Physiol. 2019 Jul 23;10:880. doi: 10.3389/fphys.2019.00880. eCollection 2019.
73 Tenofovir-associated kidney disease in Africans: a systematic review.AIDS Res Ther. 2019 Jun 6;16(1):12. doi: 10.1186/s12981-019-0227-1.
74 The angiotensin type 2 receptor and the kidney.Curr Opin Nephrol Hypertens. 2017 Jan;26(1):36-42. doi: 10.1097/MNH.0000000000000289.
75 Endothelial dysfunction and fetuin A levels before and after kidney transplantation.Transplantation. 2007 Feb 27;83(4):392-7. doi: 10.1097/01.tp.0000251647.72673.c7.
76 Relationship between aldose reductase enzyme and the signaling pathway of protein kinase C in an in vitro diabetic retinopathy model.Can J Physiol Pharmacol. 2020 Apr;98(4):243-251. doi: 10.1139/cjpp-2019-0211. Epub 2019 Nov 19.
77 Investigation of delta-aminolevulinic acid dehydratase polymorphism affecting hematopoietic, hepatic and renal toxicity from lead in Han subjects of southwestern China.Acta Physiol Hung. 2014 Mar;101(1):59-66. doi: 10.1556/APhysiol.101.2014.1.7.
78 2-Substituted 7-trifluoromethyl-thiadiazolopyrimidones as alkaline phosphatase inhibitors. Synthesis, structure activity relationship and molecular docking study. Eur J Med Chem. 2018 Jan 20; 144:116-127.
79 Molecular and Cellular Effect of Angiotensin 1-7 on Hypertensive Kidney Disease.Am J Hypertens. 2019 Apr 22;32(5):460-467. doi: 10.1093/ajh/hpz009.
80 Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes.Diabetologia. 2018 Feb;61(2):482-495. doi: 10.1007/s00125-017-4469-y. Epub 2017 Oct 30.
81 Apolipoprotein L1 Testing in African Americans: Involving the Community in Policy Discussions.Am J Nephrol. 2019;50(4):303-311. doi: 10.1159/000502675. Epub 2019 Sep 3.
82 Apolipoprotein A-IV predicts progression of chronic kidney disease: the mild to moderate kidney disease study.J Am Soc Nephrol. 2006 Feb;17(2):528-36. doi: 10.1681/ASN.2005070733. Epub 2005 Dec 28.
83 Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation.Nat Immunol. 2020 Jan;21(1):30-41. doi: 10.1038/s41590-019-0548-1. Epub 2019 Dec 9.
84 Distinct roles of arginases 1 and 2 in diabetic nephropathy.Am J Physiol Renal Physiol. 2017 Oct 1;313(4):F899-F905. doi: 10.1152/ajprenal.00158.2017. Epub 2017 Apr 26.
85 -Arrestin-1 deficiency ameliorates renal interstitial fibrosis by blocking Wnt1/-catenin signaling in mice.J Mol Med (Berl). 2018 Jan;96(1):97-109. doi: 10.1007/s00109-017-1606-5. Epub 2017 Nov 7.
86 New tubeless video-assisted thoracoscopic surgery for small pulmonary nodules.Eur J Cardiothorac Surg. 2017 Apr 1;51(4):689-693. doi: 10.1093/ejcts/ezw364.
87 Bioinformatics-based discovery of the urinary BBOX1 mRNA as a potential biomarker of diabetic kidney disease.J Transl Med. 2019 Feb 28;17(1):59. doi: 10.1186/s12967-019-1818-2.
88 Kinin B1 Receptor Is Important in the Pathogenesis of Myeloperoxidase-Specific ANCA GN.J Am Soc Nephrol. 2020 Feb;31(2):297-307. doi: 10.1681/ASN.2019010032. Epub 2019 Nov 26.
89 Biglycan is a new high-affinity ligand for CD14 in macrophages.Matrix Biol. 2019 Apr;77:4-22. doi: 10.1016/j.matbio.2018.05.006. Epub 2018 May 17.
90 Decrease of bone morphogenetic protein-7 (BMP-7) and its type II receptor (BMP-RII) in kidney of type 1-like diabetic rats.Horm Metab Res. 2009 Aug;41(8):605-11. doi: 10.1055/s-0029-1220736. Epub 2009 May 13.
91 BTK inhibition ameliorates kidney disease in spontaneous lupus nephritis.Clin Immunol. 2018 Dec;197:205-218. doi: 10.1016/j.clim.2018.10.008. Epub 2018 Oct 16.
92 Complement C5a inhibition moderates lipid metabolism and reduces tubulointerstitial fibrosis in diabetic nephropathy.Nephrol Dial Transplant. 2018 Aug 1;33(8):1323-1332. doi: 10.1093/ndt/gfx336.
93 Immune-associated renal disease found in caspase 3-deficient mice.Cell Tissue Res. 2020 Feb;379(2):323-335. doi: 10.1007/s00441-019-03084-w. Epub 2019 Aug 22.
94 Apoptosis and cell proliferation in short-term and long-term effects of radioiodine-131-induced kidney damage: an experimental and immunohistochemical study.Nucl Med Commun. 2018 Feb;39(2):131-139. doi: 10.1097/MNM.0000000000000788.
95 ALPK1 regulates streptozotocin-induced nephropathy through CCL2 and CCL5 expressions.J Cell Mol Med. 2019 Nov;23(11):7699-7708. doi: 10.1111/jcmm.14643. Epub 2019 Sep 26.
96 Vascular endothelial cadherin shedding is more severe in sepsis patients with severe acute kidney injury.Crit Care. 2019 Jan 18;23(1):18. doi: 10.1186/s13054-019-2315-y.
97 p21 and mTERT are novel markers for determining different ischemic time periods in renal ischemia-reperfusion injury.Am J Physiol Renal Physiol. 2007 Feb;292(2):F762-8. doi: 10.1152/ajprenal.00084.2006. Epub 2006 Sep 12.
98 Negligible impact of differential item functioning between Black and White dialysis patients on the Kidney Disease Quality of Life 36-item short form survey (KDQOL(TM)-36).Qual Life Res. 2018 Oct;27(10):2699-2707. doi: 10.1007/s11136-018-1879-3. Epub 2018 May 14.
99 A cytoplasmic domain mutation in ClC-Kb affects long-distance communication across the membrane.PLoS One. 2008 Jul 23;3(7):e2746. doi: 10.1371/journal.pone.0002746.
100 Identification of urinary miRNA biomarkers for detecting cisplatin-induced proximal tubular injury in rats.Toxicology. 2014 Oct 3;324:158-68. doi: 10.1016/j.tox.2014.05.004. Epub 2014 May 24.
101 Protective role of granulocyte colony-stimulating factor against adriamycin induced cardiac, renal and hepatic toxicities.Toxicol Lett. 2009 May 22;187(1):40-4. doi: 10.1016/j.toxlet.2009.01.025. Epub 2009 Feb 3.
102 Cardiotrophin-1 administration prevents the renal toxicity of iodinated contrast media in rats.Toxicol Sci. 2013 Apr;132(2):493-501. doi: 10.1093/toxsci/kft007. Epub 2013 Jan 18.
103 Interaction between galectin-3 and cystinosin uncovers a pathogenic role of inflammation inkidney involvement of cystinosis.Kidney Int. 2019 Aug;96(2):350-362. doi: 10.1016/j.kint.2019.01.029. Epub 2019 Mar 6.
104 Intrarenal Renin-Angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis.J Am Soc Nephrol. 2004 Jul;15(7):1805-15. doi: 10.1097/01.asn.0000131528.00773.a9.
105 Not all proteinuria is created equal.J Clin Invest. 2020 Jan 2;130(1):74-76. doi: 10.1172/JCI133250.
106 Upregulation of nuclear factor-B activity mediates CYP24 expression and reactive oxygen species production in indoxyl sulfate-induced chronic kidney disease.Nephrology (Carlton). 2016 Sep;21(9):774-81. doi: 10.1111/nep.12673.
107 Genetic, pathological and physiological determinants of transdermal fentanyl pharmacokinetics in 620 cancer patients of the EPOS study.Pharmacogenet Genomics. 2014 Apr;24(4):185-94. doi: 10.1097/FPC.0000000000000032.
108 CYP3A4 and CYP3A5 polymorphisms and blood pressure response to amlodipine among African-American men and women with early hypertensive renal disease. Am J Nephrol. 2010;31(2):95-103.
109 Identification of d-amino acid oxidase and propiverine interaction partners and their potential role in the propiverine-mediated nephropathy.Chem Biol Interact. 2018 Feb 1;281:69-80. doi: 10.1016/j.cbi.2017.12.023. Epub 2017 Dec 19.
110 Dopamine D3 receptor gene polymorphisms, blood pressure and nephropathy in type 1 diabetic patients.Nephrol Dial Transplant. 2004 Jun;19(6):1432-6. doi: 10.1093/ndt/gfh174. Epub 2004 Mar 5.
111 Knockout of Dual-Specificity Protein Phosphatase 5 Protects Against Hypertension-Induced Renal Injury.J Pharmacol Exp Ther. 2019 Aug;370(2):206-217. doi: 10.1124/jpet.119.258954. Epub 2019 May 22.
112 Combined hydroxyurea and ET(A) receptor blockade reduces renal injury in the humanized sickle cell mouse.Acta Physiol (Oxf). 2019 Feb;225(2):e13178. doi: 10.1111/apha.13178. Epub 2018 Sep 20.
113 Treatment of asymptomatic hyperuricemia complicated by renal damage: a controversial issue.Int Urol Nephrol. 2019 Dec;51(12):2227-2233. doi: 10.1007/s11255-019-02256-5. Epub 2019 Aug 28.
114 Ectonucleotide pyrophosphatase/phosphodiesterase 1 K173Q polymorphism is associated with diabetic nephropathy in the Taiwanese population.Genet Test Mol Biomarkers. 2011 Apr;15(4):239-42. doi: 10.1089/gtmb.2010.0148. Epub 2011 Jan 3.
115 Erythropoietin inhibits SGK1-dependent TH17 induction and TH17-dependent kidney disease.JCI Insight. 2019 Apr 23;5(10):e127428. doi: 10.1172/jci.insight.127428.
116 Genomic integration of ERR-HNF1 regulates renal bioenergetics and prevents chronic kidney disease.Proc Natl Acad Sci U S A. 2018 May 22;115(21):E4910-E4919. doi: 10.1073/pnas.1804965115. Epub 2018 May 7.
117 Effect of habitual exercise on urinary liver-type fatty acid-binding protein levels in middle-aged and older adults.Scand J Med Sci Sports. 2018 Jan;28(1):152-160. doi: 10.1111/sms.12867. Epub 2017 Apr 3.
118 Fatty-Acid Binding Protein 4 (FABP4) as a Potential Preclinical Biomarker of Drug-Induced Kidney Injury.Toxicol Sci. 2018 Dec 1;166(2):441-450. doi: 10.1093/toxsci/kfy204.
119 Role of fibroblast growth factor-binding protein in the pathogenesis of HIV-associated hemolytic uremic syndrome.Am J Physiol Regul Integr Comp Physiol. 2006 Jan;290(1):R105-13. doi: 10.1152/ajpregu.00492.2005.
120 Effect of hesperidin treatment on -Klotho/FGF-23 pathway in rats with experimentally-induced diabetes.Biomed Pharmacother. 2019 Jan;109:1206-1210. doi: 10.1016/j.biopha.2018.10.192. Epub 2018 Nov 7.
121 Identification and characterization of differentially expressed genes in Type 2 Diabetes using in silico approach.Comput Biol Chem. 2019 Apr;79:24-35. doi: 10.1016/j.compbiolchem.2019.01.010. Epub 2019 Jan 24.
122 Glucose 6-phosphate dehydrogenase and the kidney.Curr Opin Nephrol Hypertens. 2017 Jan;26(1):43-49. doi: 10.1097/MNH.0000000000000294.
123 A review of renal GH/IGF1 family gene expression in chronic kidney diseases.Growth Horm IGF Res. 2019 Oct-Dec;48-49:1-4. doi: 10.1016/j.ghir.2019.07.001. Epub 2019 Jul 16.
124 Growth hormone and chronic kidney disease.Curr Opin Nephrol Hypertens. 2019 Jan;28(1):10-15. doi: 10.1097/MNH.0000000000000468.
125 A Novel Missense GLA Mutation (p.G35V) Detected in Hemodialysis Screening Leads to Severe Systemic Manifestations of Fabry Disease in Men and Women.Nephron. 2018;138(2):147-156. doi: 10.1159/000479895. Epub 2017 Sep 12.
126 Glucagon-like peptide-1 receptor agonists and microvascular outcomes in type 2 diabetes: A systematic review and meta-analysis.Diabetes Obes Metab. 2019 Jan;21(1):188-193. doi: 10.1111/dom.13484. Epub 2018 Sep 3.
127 Analysis of three genetic markers in IgA nephropathy patients from a single region.Clin Nephrol. 2002 Apr;57(4):253-60. doi: 10.5414/cnp57253.
128 Activation of TGR5 with INT-777 attenuates oxidative stress and neuronal apoptosis via cAMP/PKC/ALDH2 pathway after subarachnoid hemorrhage in rats.Free Radic Biol Med. 2019 Nov 1;143:441-453. doi: 10.1016/j.freeradbiomed.2019.09.002. Epub 2019 Sep 4.
129 HLA-G 3' untranslated region gene variants are promising prognostic factors for BK polyomavirus replication and acute rejection after living-donor kidney transplant.Hum Immunol. 2020 Apr;81(4):141-146. doi: 10.1016/j.humimm.2019.09.011. Epub 2019 Oct 31.
130 Glutathione Transferase P1-1 an Enzyme Useful in Biomedicine and as Biomarker in Clinical Practice and in Environmental Pollution.Nutrients. 2019 Jul 27;11(8):1741. doi: 10.3390/nu11081741.
131 Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic- and GPR109a-mediated mechanisms.FASEB J. 2019 Nov;33(11):11894-11908. doi: 10.1096/fj.201901080R. Epub 2019 Jul 31.
132 -Hydroxybutyrate, a ketone body, reduces the cytotoxic effect of cisplatin via activation of HDAC5 in human renal cortical epithelial cells.Life Sci. 2019 Apr 1;222:125-132. doi: 10.1016/j.lfs.2019.03.008. Epub 2019 Mar 6.
133 Hepatocyte nuclear factor 1 and hypertensive nephropathy.Hypertension. 2008 Jun;51(6):1583-9. doi: 10.1161/HYPERTENSIONAHA.108.110163. Epub 2008 Apr 28.
134 A 17q12 chromosomal duplication associated with renal disease and esophageal atresia.Eur J Med Genet. 2011 Jul-Aug;54(4):e437-40. doi: 10.1016/j.ejmg.2011.03.010. Epub 2011 Apr 19.
135 Absence of radius and ulna in mice lacking hoxa-11 and hoxd-11.Nature. 1995 Jun 29;375(6534):791-5. doi: 10.1038/375791a0.
136 Expression of renal 11beta-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function.Eur J Endocrinol. 2005 Aug;153(2):291-9. doi: 10.1530/eje.1.01954.
137 Glucose-regulated protein 75 in foodborne disease models induces renal tubular necrosis. Food Chem Toxicol. 2019 Nov;133:110720. doi: 10.1016/j.fct.2019.110720. Epub 2019 Jul 29.
138 The reduction of heparan sulphate in the glomerular basement membrane does not augment urinary albumin excretion.Nephrol Dial Transplant. 2018 Jan 1;33(1):26-33. doi: 10.1093/ndt/gfx218.
139 IL28B rs12979860 genotype as a predictor marker of progression to BKVirus Associated nephropathy, after kidney transplantation.Sci Rep. 2017 Jul 27;7(1):6746. doi: 10.1038/s41598-017-06915-4.
140 Innovative Use of Novel Biomarkers to Improve the Safety of Renally Eliminated and Nephrotoxic Medications.Pharmacotherapy. 2018 Aug;38(8):794-803. doi: 10.1002/phar.2149. Epub 2018 Jul 13.
141 Emerging Roles of IL-33/ST2 Axis in Renal Diseases.Int J Mol Sci. 2017 Apr 7;18(4):783. doi: 10.3390/ijms18040783.
142 MicroRNA-155 Mediates Obesity-Induced Renal Inflammation and Dysfunction.Inflammation. 2019 Jun;42(3):994-1003. doi: 10.1007/s10753-019-00961-y.
143 A promoter polymorphism of the alpha 8 integrin gene and the progression of autosomal-dominant polycystic kidney disease.Nephron Clin Pract. 2008;108(3):c169-75. doi: 10.1159/000116887. Epub 2008 Feb 14.
144 CPUY192018, a potent inhibitor of the Keap1-Nrf2 protein-protein interaction, alleviates renal inflammation in mice by restricting oxidative stress and NF-B activation.Redox Biol. 2019 Sep;26:101266. doi: 10.1016/j.redox.2019.101266. Epub 2019 Jul 2.
145 Pancreatic kallikrein protects against diabetic retinopathy in KK Cg-A(y)/J and high-fat diet/streptozotocin-induced mouse models of type 2 diabetes.Diabetologia. 2019 Jun;62(6):1074-1086. doi: 10.1007/s00125-019-4838-9. Epub 2019 Mar 5.
146 Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice.Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10190-5. doi: 10.1073/pnas.1005144107. Epub 2010 May 17.
147 Serum levels of NGAL and cystatin C as markers of early kidney dysfunction in patients with obstructive sleep apnea syndrome.Sleep Breath. 2019 Mar;23(1):161-169. doi: 10.1007/s11325-018-1677-8. Epub 2018 Jun 26.
148 Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes.Mol Biosyst. 2010 May;6(5):909-21. doi: 10.1039/b914182k. Epub 2010 Mar 23.
149 Causes and consequences of lipoprotein(a) abnormalities in kidney disease.Clin Exp Nephrol. 2014 Apr;18(2):234-7. doi: 10.1007/s10157-013-0875-8. Epub 2013 Oct 16.
150 Anti-LRP2 Nephropathy With Abundant IgG4-Positive Plasma Cells: A Case Report.Am J Kidney Dis. 2019 Jul;74(1):132-137. doi: 10.1053/j.ajkd.2018.12.039. Epub 2019 Mar 12.
151 Blockade of myeloid differentiation protein 2 prevents obesity-induced inflammation and nephropathy.J Cell Mol Med. 2017 Dec;21(12):3776-3786. doi: 10.1111/jcmm.13287. Epub 2017 Aug 2.
152 The effect of thermosensitive liposomal formulations on loading and release of high molecular weight biomolecules.Int J Pharm. 2017 May 30;524(1-2):279-289. doi: 10.1016/j.ijpharm.2017.03.090. Epub 2017 Apr 2.
153 Absence of the Lectin Activation Pathway of Complement Ameliorates Proteinuria-Induced Renal Injury.Front Immunol. 2019 Sep 23;10:2238. doi: 10.3389/fimmu.2019.02238. eCollection 2019.
154 Macrophage migration inhibitory factor -173G/C gene polymorphism increases the risk of renal disease: a meta-analysis.Nephrology (Carlton). 2015 Feb;20(2):68-76. doi: 10.1111/nep.12353.
155 Chromosome 1 localization of a gene for autosomal dominant medullary cystic kidney disease.Hum Mol Genet. 1998 May;7(5):905-11. doi: 10.1093/hmg/7.5.905.
156 Matrix Metalloproteinase-7 Is a Urinary Biomarker and Pathogenic Mediator of Kidney Fibrosis.J Am Soc Nephrol. 2017 Feb;28(2):598-611. doi: 10.1681/ASN.2016030354. Epub 2016 Sep 13.
157 An overlap of antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis and IgG4-related kidney disease.Clin Chim Acta. 2020 Feb;501:12-19. doi: 10.1016/j.cca.2019.11.030. Epub 2019 Dec 2.
158 Chemical Strike against a Dominant-Inherited MUC1-Frameshifted Protein Associated with Progressive Kidney Disease.Trends Mol Med. 2019 Oct;25(10):821-823. doi: 10.1016/j.molmed.2019.08.011. Epub 2019 Sep 11.
159 NAG-targeting fluorescence based probe for precision diagnosis of kidney injury.Chem Commun (Camb). 2019 Feb 7;55(13):1955-1958. doi: 10.1039/c8cc10311a.
160 Evaluation of inducible nitric oxide synthase inhibition on kidney function and structure in high-fat diet-induced kidney disease.Exp Physiol. 2018 Jan 1;103(1):125-140. doi: 10.1113/EP086594. Epub 2017 Nov 22.
161 Targeted disruption of guanylyl cyclase-A/natriuretic peptide receptor-A gene provokes renal fibrosis and remodeling in null mutant mice: role of proinflammatory cytokines.Endocrinology. 2010 Dec;151(12):5841-50. doi: 10.1210/en.2010-0655. Epub 2010 Sep 29.
162 Inhibition of renal NQO1 activity by dicoumarol suppresses nitroreduction of aristolochic acid I and attenuates its nephrotoxicity.Toxicol Sci. 2011 Aug;122(2):288-96. doi: 10.1093/toxsci/kfr138. Epub 2011 May 24.
163 Vascular and inflammatory mineralocorticoid receptors in kidney disease.Acta Physiol (Oxf). 2020 Feb;228(2):e13390. doi: 10.1111/apha.13390. Epub 2019 Oct 3.
164 Phospholipase A2 Receptor Antibody IgG4 Subclass Improves Sensitivity and Specificity in the Diagnosis of Idiopathic Membranous Nephropathy.Kidney Blood Press Res. 2019;44(4):848-857. doi: 10.1159/000500456. Epub 2019 Jun 26.
165 Circulating antibodies against M-type phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in Chinese patients with membranous nephropathy.Int Urol Nephrol. 2019 Aug;51(8):1371-1377. doi: 10.1007/s11255-019-02146-w. Epub 2019 Jun 21.
166 Renal and pancreatic calcification during treatment of infantile spasms with ACTH.Lancet. 1984 Apr 21;1(8382):901. doi: 10.1016/s0140-6736(84)91355-2.
167 Fenofibrate attenuates cardiac and renal alterations in young salt-loaded spontaneously hypertensive stroke-prone rats through mitochondrial protection.J Hypertens. 2018 May;36(5):1129-1146. doi: 10.1097/HJH.0000000000001651.
168 Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis.Nat Med. 2007 Nov;13(11):1349-58. doi: 10.1038/nm1667. Epub 2007 Nov 4.
169 Genome-wide association study identifies susceptibility loci for IgA nephropathy.Nat Genet. 2011 Mar 13;43(4):321-7. doi: 10.1038/ng.787.
170 Vitamin D, bone alkaline phosphatase and parathyroid hormone in healthy subjects and haemodialysed patients from West Africa: impact of reference ranges and parathyroid hormone generation assays on the KDIGO guidelines.Clin Kidney J. 2018 Sep 5;12(2):288-293. doi: 10.1093/ckj/sfy074. eCollection 2019 Apr.
171 Podocyte-specific Rac1 deficiency ameliorates podocyte damage and proteinuria in STZ-induced diabetic nephropathy in mice.Cell Death Dis. 2018 Mar 1;9(3):342. doi: 10.1038/s41419-018-0353-z.
172 Integrated transcriptomic and proteomic evaluation of gentamicin nephrotoxicity in rats.Toxicol Appl Pharmacol. 2012 Jan 1;258(1):124-33. doi: 10.1016/j.taap.2011.10.015. Epub 2011 Oct 29.
173 Role of p90RSK in Kidney and Other Diseases.Int J Mol Sci. 2019 Feb 23;20(4):972. doi: 10.3390/ijms20040972.
174 Omega-3 fatty acid decreases oleic acid by decreasing SCD-1 expression in the liver and kidney of a cyclosporine-induced nephropathy rat model.Ren Fail. 2019 Nov;41(1):211-219. doi: 10.1080/0886022X.2019.1591996.
175 Signal regulatory protein protects podocytes through promoting autophagic activity.JCI Insight. 2019 Mar 19;5(9):e124747. doi: 10.1172/jci.insight.124747.
176 The role and function of HDL in patients with diabetes mellitus and the related cardiovascular risk.Lipids Health Dis. 2017 Oct 30;16(1):207. doi: 10.1186/s12944-017-0594-3.
177 OS9 Protein Interacts with Na-K-2Cl Co-transporter (NKCC2) and Targets Its Immature Form for the Endoplasmic Reticulum-associated Degradation Pathway.J Biol Chem. 2016 Feb 26;291(9):4487-502. doi: 10.1074/jbc.M115.702514. Epub 2015 Dec 31.
178 Association of rs11643718 SLC12A3 and rs741301 ELMO1 Variants with Diabetic Nephropathy in South Indian Population.Ann Hum Genet. 2016 Nov;80(6):336-341. doi: 10.1111/ahg.12174. Epub 2016 Oct 4.
179 A Variant of Peptide Transporter 2 Predicts the Severity of Porphyria-Associated Kidney Disease.J Am Soc Nephrol. 2017 Jun;28(6):1924-1932. doi: 10.1681/ASN.2016080918. Epub 2016 Dec 28.
180 Neutrophil/lymphocyte ratio elevation in renal dysfunction is caused by distortion of leukocyte hematopoiesis in bone marrow.Ren Fail. 2019 Nov;41(1):284-293. doi: 10.1080/0886022X.2019.1597736.
181 Ameliorative effects of SLC22A2 gene polymorphism 808 G/T and cimetidine on cisplatin-induced nephrotoxicity in Chinese cancer patients. Food Chem Toxicol. 2012 Jul;50(7):2289-93. doi: 10.1016/j.fct.2012.03.077. Epub 2012 Apr 16.
182 Expression levels of renal organic anion transporters (OATs) and their correlation with anionic drug excretion in patients with renal diseases. Pharm Res. 2004 Jan;21(1):61-7.
183 SLC2A9 (GLUT9) mediates urate reabsorption in the mouse kidney.Pflugers Arch. 2018 Dec;470(12):1739-1751. doi: 10.1007/s00424-018-2190-4. Epub 2018 Aug 13.
184 CRISPR/Cas9 genome editing of SLC37A4 gene elucidates the role of molecular markers of endoplasmic reticulum stress and apoptosis in renal involvement in glycogen storage disease type Ib.Gene. 2019 Jun 30;703:17-25. doi: 10.1016/j.gene.2019.04.002. Epub 2019 Apr 3.
185 Ondansetron can enhance cisplatin-induced nephrotoxicity via inhibition of multiple toxin and extrusion proteins (MATEs).Toxicol Appl Pharmacol. 2013 Nov 15;273(1):100-9. doi: 10.1016/j.taap.2013.08.024. Epub 2013 Aug 31.
186 Renal SGLT mRNA expression in human health and disease: a study in two cohorts.Am J Physiol Renal Physiol. 2019 Nov 1;317(5):F1224-F1230. doi: 10.1152/ajprenal.00370.2019. Epub 2019 Sep 23.
187 A common NHE3 single-nucleotide polymorphism has normal function and sensitivity to regulatory ligands. Am J Physiol Gastrointest Liver Physiol. 2017 Aug 1;313(2):G129-G137.
188 LncRNA PRINS is involved in the development of nephropathy in patients with diabetes via interaction with Smad7.Exp Ther Med. 2019 Apr;17(4):3203-3208. doi: 10.3892/etm.2019.7307. Epub 2019 Feb 25.
189 Instigation of NLRP3 inflammasome activation and glomerular injury in mice on the high fat diet: role of acid sphingomyelinase gene.Oncotarget. 2016 Apr 5;7(14):19031-44. doi: 10.18632/oncotarget.8023.
190 Associations between FGF21, osteonectin and bone turnover markers in type 2 diabetic patients with albuminuria.J Diabetes Complications. 2017 Mar;31(3):583-588. doi: 10.1016/j.jdiacomp.2016.11.012. Epub 2016 Nov 17.
191 Reduced TFAP2A function causes variable optic fissure closure and retinal defects and sensitizes eye development to mutations in other morphogenetic regulators.Hum Genet. 2009 Dec;126(6):791-803. doi: 10.1007/s00439-009-0730-x.
192 Conditional knockout of TGF-RII /Smad2 signals protects against acute renal injury by alleviating cell necroptosis, apoptosis and inflammation.Theranostics. 2019 Oct 21;9(26):8277-8293. doi: 10.7150/thno.35686. eCollection 2019.
193 T4-Ac-SDKP pathway: Any relevance for the cardiovascular system?.Can J Physiol Pharmacol. 2019 Jul;97(7):589-599. doi: 10.1139/cjpp-2018-0570. Epub 2019 Mar 9.
194 Characterization of BAFF and APRIL subfamily receptors in rainbow trout (Oncorhynchus mykiss). Potential role of the BAFF / APRIL axis in the pathogenesis of proliferative kidney disease.PLoS One. 2017 Mar 21;12(3):e0174249. doi: 10.1371/journal.pone.0174249. eCollection 2017.
195 A replication study from Chinese supports association between lupus-risk allele in TNFSF4 and renal disorder.Biomed Res Int. 2013;2013:597921. doi: 10.1155/2013/597921. Epub 2013 Jul 1.
196 TREM-1 regulates macrophage polarization in ureteral obstruction.Kidney Int. 2014 Dec;86(6):1174-86. doi: 10.1038/ki.2014.205. Epub 2014 Jun 11.
197 The Unexpected Effects of L-Carnitine Supplementation on Lipid Metabolism in Hemodialysis Patients.Kidney Blood Press Res. 2018;43(4):1113-1120. doi: 10.1159/000491807. Epub 2018 Jul 17.
198 Verapamil Attenuated Prediabetic Neuropathy in High-Fat Diet-Fed Mice through Inhibiting TXNIP-Mediated Apoptosis and Inflammation.Oxid Med Cell Longev. 2019 Jan 10;2019:1896041. doi: 10.1155/2019/1896041. eCollection 2019.
199 Plasma Urotensin II levels in children and adolescents with chronic kidney disease: a single-centre study.BMC Nephrol. 2017 Mar 31;18(1):113. doi: 10.1186/s12882-017-0530-9.
200 Gender differences in mRNA expression of ATP-binding cassette efflux and bile acid transporters in kidney, liver, and intestine of 5/6 nephrectomized rats.Drug Metab Dispos. 2008 Jan;36(1):16-23. doi: 10.1124/dmd.107.014845. Epub 2007 Sep 12.
201 Evidence of alpha1-adrenoceptor functional changes in omental arteries of patients with end-stage renal disease.Auton Autacoid Pharmacol. 2008 Jan;28(1):19-27. doi: 10.1111/j.1474-8673.2007.00413.x.
202 Circulating ACE2 in Cardiovascular and Kidney Diseases.Curr Med Chem. 2017;24(30):3231-3241. doi: 10.2174/0929867324666170414162841.
203 Serum vascular adhesion protein-1 is higher in subjects with early stages of chronic kidney disease.Clin Biochem. 2008 Nov;41(16-17):1362-7. doi: 10.1016/j.clinbiochem.2008.06.019. Epub 2008 Jul 9.
204 Biliverdin Reductase A (BVRA) Mediates Macrophage Expression of Interleukin-10 in Injured Kidney.Int J Mol Sci. 2015 Sep 18;16(9):22621-35. doi: 10.3390/ijms160922621.
205 Targeting C3a/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin A nephropathy in mice.Clin Exp Immunol. 2017 Jul;189(1):60-70. doi: 10.1111/cei.12961. Epub 2017 Apr 10.
206 Erythrocyte zinc and carbonic anhydrase levels in nondialyzed chronic kidney disease patients.Clin Biochem. 2004 Jan;37(1):67-71. doi: 10.1016/j.clinbiochem.2003.03.001.
207 Cholesteryl ester transfer protein activity and cardiovascular events in patients with chronic kidney disease stage V.Nephrol Dial Transplant. 2008 Nov;23(11):3599-604. doi: 10.1093/ndt/gfn296. Epub 2008 May 25.
208 Cadmium Induces Glomerular Endothelial Cell-Specific Expression of Complement Factor H via the -1635 AP-1 Binding Site.J Immunol. 2019 Feb 15;202(4):1210-1218. doi: 10.4049/jimmunol.1800081. Epub 2019 Jan 14.
209 Evidence for concurrent effects of exposure to environmental cadmium and lead on hepatic CYP2A6 phenotype and renal function biomarkers in nonsmokers.Environ Health Perspect. 2004 Nov;112(15):1512-8. doi: 10.1289/ehp.7192.
210 Dickkopf-3 in aberrant endothelial secretome triggers renal fibroblast activation and endothelial-mesenchymal transition.Nephrol Dial Transplant. 2019 Jan 1;34(1):49-62. doi: 10.1093/ndt/gfy100.
211 The fatty acid-binding protein-2 A54T polymorphism is associated with renal disease in patients with type 2 diabetes.Diabetes. 2005 Nov;54(11):3326-30. doi: 10.2337/diabetes.54.11.3326.
212 Supplementation with N-3 long-chain polyunsaturated fatty acids or olive oil in men and women with renal disease induces differential changes in the DNA methylation of FADS2 and ELOVL5 in peripheral blood mononuclear cells.PLoS One. 2014 Oct 17;9(10):e109896. doi: 10.1371/journal.pone.0109896. eCollection 2014.
213 Homozygous frameshift mutations in FAT1 cause a syndrome characterized by colobomatous-microphthalmia, ptosis, nephropathy and syndactyly.Nat Commun. 2019 Mar 12;10(1):1180. doi: 10.1038/s41467-019-08547-w.
214 Serum fibrinogen levels are an independent predictor of mortality in patients with chronic kidney disease (CKD) stages 3 and 4.Kidney Int Suppl. 2008 Dec;(111):S67-70. doi: 10.1038/ki.2008.519.
215 Reactivity to N-Terminally Truncated GAD65(96-585) Identifies GAD Autoantibodies That Are More Closely Associated With Diabetes Progression in Relatives of Patients With Type 1 Diabetes.Diabetes. 2015 Sep;64(9):3247-52. doi: 10.2337/db14-1694. Epub 2015 May 22.
216 A Novel Inhibitor of Homeodomain Interacting Protein Kinase 2 Mitigates Kidney Fibrosis through Inhibition of the TGF-1/Smad3 Pathway.J Am Soc Nephrol. 2017 Jul;28(7):2133-2143. doi: 10.1681/ASN.2016080841. Epub 2017 Feb 20.
217 Exacerbated autoimmunity in the absence of TLR9 in MRL.Fas(lpr) mice depends on Ifnar1.J Immunol. 2013 Apr 15;190(8):3889-94. doi: 10.4049/jimmunol.1203525. Epub 2013 Mar 6.
218 Analysis of killer cell immunoglobulin-like receptors and their human leukocyte antigen-ligands gene polymorphisms in Iranian patients with systemic lupus erythematosus.Lupus. 2016 Oct;25(11):1244-53. doi: 10.1177/0961203316638931. Epub 2016 Mar 16.
219 Amelioration of circulating lipoprotein profile and proteinuria in a patient with LCAT deficiency due to a novel mutation (Cys74Tyr) in the lid region of LCAT under a fat-restricted diet and ARB treatment.Atherosclerosis. 2013 May;228(1):193-7. doi: 10.1016/j.atherosclerosis.2013.02.034. Epub 2013 Mar 14.
220 Intragraft Antiviral-Specific Gene Expression as a Distinctive Transcriptional Signature for Studies in Polyomavirus-Associated Nephropathy.Transplantation. 2016 Oct;100(10):2062-70. doi: 10.1097/TP.0000000000001214.
221 Up-regulation of Cks1 and Skp2 with TNF/NF-B signaling in chronic progressive nephropathy.Genes Cells. 2011 Nov;16(11):1110-20. doi: 10.1111/j.1365-2443.2011.01553.x.
222 MYH9 E1841K Mutation Augments Proteinuria and Podocyte Injury and Migration.J Am Soc Nephrol. 2018 Jan;29(1):155-167. doi: 10.1681/ASN.2015060707. Epub 2017 Oct 9.
223 Reactive oxygen species deficiency induces autoimmunity with type 1 interferon signature.Antioxid Redox Signal. 2014 Dec 1;21(16):2231-45. doi: 10.1089/ars.2013.5828. Epub 2014 Jul 29.
224 NEK8 mutations affect ciliary and centrosomal localization and may cause nephronophthisis. J Am Soc Nephrol. 2008 Mar;19(3):587-92. doi: 10.1681/ASN.2007040490. Epub 2008 Jan 16.
225 Filtering through the role of NRF2 in kidney disease.Arch Pharm Res. 2020 Mar;43(3):361-369. doi: 10.1007/s12272-019-01177-2. Epub 2019 Aug 1.
226 Phloretin ameliorates hyperuricemia-induced chronic renal dysfunction through inhibiting NLRP3 inflammasome and uric acid reabsorption.Phytomedicine. 2020 Jan;66:153111. doi: 10.1016/j.phymed.2019.153111. Epub 2019 Oct 16.
227 Genetic susceptibility and loss of Nr4a1 enhances macrophage-mediated renal injury in CKD.J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10.
228 Kidney dysfunction in patients with pulmonary arterial hypertension.Pulm Circ. 2017 Mar 13;7(1):38-54. doi: 10.1086/690018. eCollection 2017 Mar.
229 Antagonism of PDGF-D by human antibody CR002 prevents renal scarring in experimental glomerulonephritis.J Am Soc Nephrol. 2006 Apr;17(4):1054-62. doi: 10.1681/ASN.2005070683. Epub 2006 Mar 1.
230 Postnatal maturation of mouse medullo-spinal cerebrospinal fluid-contacting neurons.Neuroscience. 2017 Feb 20;343:39-54. doi: 10.1016/j.neuroscience.2016.11.028. Epub 2016 Dec 7.
231 Urinary pro-thrombotic, anti-thrombotic, and fibrinolytic molecules as biomarkers of lupus nephritis.Arthritis Res Ther. 2019 Jul 18;21(1):176. doi: 10.1186/s13075-019-1959-y.
232 Role of calcineurin (CN) in kidney glomerular podocyte: CN inhibitor ameliorated proteinuria by inhibiting the redistribution of CN at the slit diaphragm.Physiol Rep. 2016 Mar;4(6):e12679. doi: 10.14814/phy2.12679.
233 Protein kinase C stabilizes -catenin and regulates its subcellular localization in podocytes.J Biol Chem. 2017 Jul 21;292(29):12100-12110. doi: 10.1074/jbc.M117.775700. Epub 2017 May 24.
234 SerpinC1/Antithrombin III in kidney-related diseases.Clin Sci (Lond). 2017 May 1;131(9):823-831. doi: 10.1042/CS20160669.
235 Refinement of the HIVAN1 Susceptibility Locus on Chr. 3A1-A3 via Generation of Sub-Congenic Strains.PLoS One. 2016 Oct 13;11(10):e0163860. doi: 10.1371/journal.pone.0163860. eCollection 2016.
236 Thiamine transporter 2 is involved in high glucose-induced damage and altered thiamine availability in cell models of diabetic retinopathy.Diab Vasc Dis Res. 2020 Jan-Feb;17(1):1479164119878427. doi: 10.1177/1479164119878427. Epub 2019 Nov 14.
237 Calorie restriction modulates renal expression of sterol regulatory element binding proteins, lipid accumulation, and age-related renal disease.J Am Soc Nephrol. 2005 Aug;16(8):2385-94. doi: 10.1681/ASN.2004080701. Epub 2005 Jun 8.
238 Deficiency of liver sinusoidal scavenger receptors stabilin-1 and -2 in mice causes glomerulofibrotic nephropathy via impaired hepatic clearance of noxious blood factors.J Clin Invest. 2011 Feb;121(2):703-14. doi: 10.1172/JCI44740.
239 Receptor structure-based discovery of non-metabolite agonists for the succinate receptor GPR91.Mol Metab. 2017 Dec;6(12):1585-1596. doi: 10.1016/j.molmet.2017.09.005. Epub 2017 Sep 30.
240 [Effect of Kangxianling on Smads signal pathway molecules in rats with adriamycin induced nephropathy].Zhongguo Zhong Xi Yi Jie He Za Zhi. 2007 Dec;27(12):1094-8.
241 MicroRNA-135a is involved in podocyte injury in a transient receptor potential channel 1-dependent manner.Int J Mol Med. 2017 Nov;40(5):1511-1519. doi: 10.3892/ijmm.2017.3152. Epub 2017 Sep 25.
242 Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020 Feb;22(2):245-257. doi: 10.1038/s41436-019-0686-8. Epub 2019 Nov 6.
243 Tracking GLUT2 Translocation by Live-Cell Imaging.Methods Mol Biol. 2018;1713:241-254. doi: 10.1007/978-1-4939-7507-5_18.
244 GDC-0879, a BRAF(V600E) Inhibitor, Protects Kidney Podocytes from Death.Cell Chem Biol. 2018 Feb 15;25(2):175-184.e4. doi: 10.1016/j.chembiol.2017.11.006. Epub 2017 Dec 14.
245 Dysfunction in macrophage toll-like receptor signaling caused by an inborn error of cationic amino acid transport.Mol Immunol. 2015 Oct;67(2 Pt B):416-25. doi: 10.1016/j.molimm.2015.07.006. Epub 2015 Jul 22.
246 Urinary metabolites along with common and raregenetic variations are associated with incidentchronic kidney disease.Kidney Int. 2017 Jun;91(6):1426-1435. doi: 10.1016/j.kint.2017.01.007. Epub 2017 Mar 14.
247 Building a bridge between clinical and basic research: the phenotypic elements of familial predisposition to type 1 diabetes.Curr Med Chem. 2007;14(5):555-67. doi: 10.2174/092986707780059689.
248 Therapeutic apheresis in neurological, nephrological and gastrointestinal diseases.Transfus Apher Sci. 2019 Jun;58(3):266-272. doi: 10.1016/j.transci.2019.04.011. Epub 2019 Apr 19.
249 Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease.Pharmacogenet Genomics. 2008 Nov;18(11):943-53. doi: 10.1097/FPC.0b013e32830e1e16.
250 Reduced Renal Methylarginine Metabolism Protects against Progressive Kidney Damage.J Am Soc Nephrol. 2015 Dec;26(12):3045-59. doi: 10.1681/ASN.2014030280. Epub 2015 Apr 8.
251 N-acetyltransferase 8, a positional candidate for blood pressure and renal regulation: resequencing, association and in silico study.BMC Med Genet. 2008 Apr 10;9:25. doi: 10.1186/1471-2350-9-25.
252 Paraoxonase 2 (PON2) polymorphisms and development of renal dysfunction in type 2 diabetes: UKPDS 76.Diabetologia. 2006 Dec;49(12):2892-9. doi: 10.1007/s00125-006-0436-8. Epub 2006 Oct 3.
253 Identification of candidate disease genes by EST alignments, synteny, and expression and verification of Ensembl genes on rat chromosome 1q43-54.Genome Res. 2004 Apr;14(4):640-50. doi: 10.1101/gr.1932304.
254 Potentially harmful advantage to athletes: a putative connection between UGT2B17 gene deletion polymorphism and renal disorders with prolonged use of anabolic androgenic steroids.Subst Abuse Treat Prev Policy. 2010 Apr 29;5:7. doi: 10.1186/1747-597X-5-7.
255 Chaperonin-containing t-complex protein-1 subunit as a possible biomarker for the phase of glomerular hyperfiltration of diabetic nephropathy.Dis Markers. 2015;2015:548101. doi: 10.1155/2015/548101. Epub 2015 Apr 5.
256 Recessive mutation in tetraspanin CD151 causes Kindler syndrome-like epidermolysis bullosa with multi-systemic manifestations including nephropathy.Matrix Biol. 2018 Mar;66:22-33. doi: 10.1016/j.matbio.2017.11.003. Epub 2017 Nov 11.
257 The clinical significance of plasma CFHR 1-5 in lupus nephropathy.Immunobiology. 2019 May;224(3):339-346. doi: 10.1016/j.imbio.2019.03.005. Epub 2019 Apr 3.
258 Complement factor Hrelated 3 overexpression affects hepatocellular carcinoma proliferation and apoptosis.Mol Med Rep. 2019 Sep;20(3):2694-2702. doi: 10.3892/mmr.2019.10514. Epub 2019 Jul 23.
259 Risk factors of cardiac surgery-associated acute kidney injury: development and validation of a perioperative predictive nomogram.J Nephrol. 2019 Dec;32(6):937-945. doi: 10.1007/s40620-019-00624-z. Epub 2019 Jun 26.
260 Deletion of the formin Diaph1 protects from structural and functional abnormalities in the murine diabetic kidney.Am J Physiol Renal Physiol. 2018 Dec 1;315(6):F1601-F1612. doi: 10.1152/ajprenal.00075.2018. Epub 2018 Aug 22.
261 Association analysis of the ephrin-B2 gene in African-Americans with end-stage renal disease.Am J Nephrol. 2008;28(6):914-20. doi: 10.1159/000141934. Epub 2008 Jun 26.
262 Further evidence for the association of MMP9 with nephropathy in type 2 diabetes and application of DNA pooling technology to candidate gene screening.J Nephrol. 2008 May-Jun;21(3):400-5.
263 Patient-iPSC-Derived Kidney Organoids Show Functional Validation of a Ciliopathic Renal Phenotype and Reveal Underlying Pathogenetic Mechanisms.Am J Hum Genet. 2018 May 3;102(5):816-831. doi: 10.1016/j.ajhg.2018.03.014. Epub 2018 Apr 26.
264 IL-17C/IL-17 Receptor E Signaling in CD4(+) T Cells Promotes T(H)17 Cell-Driven Glomerular Inflammation.J Am Soc Nephrol. 2018 Apr;29(4):1210-1222. doi: 10.1681/ASN.2017090949. Epub 2018 Feb 26.
265 Inversin correlates with the malignant phenotype of non-small cell lung cancer and promotes the invasiveness of lung cancer cells.Tumour Biol. 2017 Jun;39(6):1010428317691177. doi: 10.1177/1010428317691177.
266 Mnire's Disease: Molecular Analysis of Aquaporins 2, 3 and Potassium Channel KCNE1 Genes in Brazilian Patients.Otol Neurotol. 2016 Sep;37(8):1117-21. doi: 10.1097/MAO.0000000000001136.
267 Effects of MCF2L2, ADIPOQ and SOX2 genetic polymorphisms on the development of nephropathy in type 1 Diabetes Mellitus.BMC Med Genet. 2010 Jul 28;11:116. doi: 10.1186/1471-2350-11-116.
268 Elevated levels of renal and circulating Nop-7-associated 2 (NSA2) in rat and mouse models of diabetes, in mesangial cells in vitro and in patients with diabetic nephropathy.Diabetologia. 2012 Mar;55(3):825-34. doi: 10.1007/s00125-011-2373-4. Epub 2011 Nov 18.
269 Studies of the variability of the hepatocyte nuclear factor-1beta (HNF-1beta / TCF2) and the dimerization cofactor of HNF-1 (DcoH / PCBD) genes in relation to type 2 diabetes mellitus and beta-cell function.Hum Mutat. 2001 Oct;18(4):356-7. doi: 10.1002/humu.1201.
270 Resistin as a potential marker of renal disease in lupus nephritis.Clin Exp Immunol. 2015 Mar;179(3):435-43. doi: 10.1111/cei.12473.
271 Anti-SmD1 antibodies are associated with renal disorder, seizures, and pulmonary arterial hypertension in Chinese patients with active SLE.Sci Rep. 2017 Aug 8;7(1):7617. doi: 10.1038/s41598-017-08099-3.
272 Chromosome 2q31.1 associates with ESRD in women with type 1 diabetes.J Am Soc Nephrol. 2013 Oct;24(10):1537-43. doi: 10.1681/ASN.2012111122. Epub 2013 Sep 12.
273 Characteristics of Liver Disease in 100 Individuals With Joubert Syndrome Prospectively Evaluated at a Single Center.J Pediatr Gastroenterol Nutr. 2018 Mar;66(3):428-435. doi: 10.1097/MPG.0000000000001816.
274 Urinary Cell Adhesion Molecule 1 Is a Novel Biomarker That Links Tubulointerstitial Damage to Glomerular Filtration Rates in Chronic Kidney Disease.Front Cell Dev Biol. 2019 Jun 27;7:111. doi: 10.3389/fcell.2019.00111. eCollection 2019.
275 In vivo role of CLC chloride channels in the kidney.Am J Physiol Renal Physiol. 2000 Nov;279(5):F802-8. doi: 10.1152/ajprenal.2000.279.5.F802.
276 Extrarenal effects on the pathogenesis and relapse of idiopathic nephrotic syndrome in Buffalo/Mna rats.J Clin Invest. 2002 Feb;109(4):491-8. doi: 10.1172/JCI12858.
277 Small proteoglycans of normal adult human kidney: distinct expression patterns of decorin, biglycan, fibromodulin, and lumican.Kidney Int. 2000 Oct;58(4):1557-68. doi: 10.1046/j.1523-1755.2000.00317.x.
278 G-protein beta(3)-subunit C825T genotype and nephropathy in diabetes mellitus.Nephrol Dial Transplant. 2000 Sep;15(9):1384-7. doi: 10.1093/ndt/15.9.1384.
279 Confirmation of CLIM2/LMX1B interaction by yeast two-hybrid screening and analysis of its involvement in nail-patella syndrome.Int J Mol Med. 2003 Jul;12(1):79-82.
280 Aquaporin expression in normal human kidney and in renal disease.J Am Soc Nephrol. 2003 Oct;14(10):2581-7. doi: 10.1097/01.asn.0000089566.28106.f6.
281 Novel vertebrate genes and putative regulatory elements identified at kidney disease and NR2E1/fierce loci.Genomics. 2002 Jul;80(1):45-53. doi: 10.1006/geno.2002.6795.
282 A 11 Mb YAC-based contig spanning the familial juvenile nephronophthisis region (NPH1) located on chromosome 2q.Genomics. 1995 Dec 10;30(3):514-20. doi: 10.1006/geno.1995.1272.
283 Haplotypes of the HRES-1 endogenous retrovirus are associated with development and disease manifestations of systemic lupus erythematosus.Arthritis Rheum. 2008 Feb;58(2):532-40. doi: 10.1002/art.23161.
284 Immunoglobulin heavy chain switch region restriction fragment length polymorphisms are associated with renal disease.Clin Exp Immunol. 1986 Nov;66(2):406-13.
285 Renal angiomyolipomas, cysts, and cancer in tuberous sclerosis complex.Semin Pediatr Neurol. 1998 Dec;5(4):269-75. doi: 10.1016/s1071-9091(98)80005-3.
286 ABCG8 polymorphisms and renal disease in type 2 diabetic patients.Metabolism. 2015 Jun;64(6):713-9. doi: 10.1016/j.metabol.2015.03.005. Epub 2015 Mar 14.
287 Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.Am J Nephrol. 2015;42(2):99-106. doi: 10.1159/000439448. Epub 2015 Sep 8.
288 Aquaporin 11 rs2276415 variant and progression of chronic kidney disease.Nephrol Dial Transplant. 2019 Jun 1;34(6):970-973. doi: 10.1093/ndt/gfy219.
289 Obesity and chronic kidney disease progression-the role of a new adipocytokine: C1q/tumour necrosis factor-related protein-1.Clin Kidney J. 2018 Oct 11;12(3):420-426. doi: 10.1093/ckj/sfy095. eCollection 2019 Jun.
290 An intergenic region on chromosome 13q33.3 is associated with the susceptibility to kidney disease in type 1 and 2 diabetes.Kidney Int. 2011 Jul;80(1):105-11. doi: 10.1038/ki.2011.64. Epub 2011 Mar 16.
291 Cytoglobin/STAP, its unique localization in splanchnic fibroblast-like cells and function in organ fibrogenesis.Lab Invest. 2004 Jan;84(1):91-101. doi: 10.1038/labinvest.3700013.
292 An immunological renal disease in transgenic mice that overexpress Fli-1, a member of the ets family of transcription factor genes.Mol Cell Biol. 1995 Dec;15(12):6961-70. doi: 10.1128/MCB.15.12.6961.
293 Allelic variations in the CYBA gene of NADPH oxidase and risk of kidney complications in patients with type 1 diabetes.Free Radic Biol Med. 2015 Sep;86:16-24. doi: 10.1016/j.freeradbiomed.2015.04.002. Epub 2015 Apr 8.
294 Evaluation of associations between single nucleotide polymorphisms in the FRMD3 and CARS genes and diabetic nephropathy in a Kuwaiti population.Genet Mol Res. 2016 Jan 29;15(1). doi: 10.4238/gmr.15017619.
295 Molecular screening of the human glutamine-fructose-6-phosphate amidotransferase 1 (GFPT1) gene and association studies with diabetes and diabetic nephropathy.Mol Genet Metab. 2004 Aug;82(4):321-8. doi: 10.1016/j.ymgme.2004.05.004.
296 GPRC5b Modulates Inflammatory Response in Glomerular Diseases via NF-B Pathway.J Am Soc Nephrol. 2019 Sep;30(9):1573-1586. doi: 10.1681/ASN.2019010089. Epub 2019 Jul 8.
297 Overlap of abnormal photoreceptor development and progressive degeneration in Leber congenital amaurosis caused by NPHP5 mutation.Hum Mol Genet. 2016 Oct 1;25(19):4211-4226. doi: 10.1093/hmg/ddw254. Epub 2016 Aug 9.
298 Distribution of Killer cell immunoglobulin like receptor genes in end stage renal disease among North Indian population.Hum Immunol. 2013 Oct;74(10):1339-45. doi: 10.1016/j.humimm.2013.06.015. Epub 2013 Jun 15.
299 Krppel-like Factor 15: A Potential Therapeutic Target For Kidney Disease.Int J Biol Sci. 2019 Jul 21;15(9):1955-1961. doi: 10.7150/ijbs.34838. eCollection 2019.
300 Matrix Gla protein T-138C polymorphism is associated with carotid intima media thickness and predicts mortality in patients with diabetic nephropathy.J Diabetes Complications. 2017 Oct;31(10):1527-1532. doi: 10.1016/j.jdiacomp.2017.06.012. Epub 2017 Jun 30.
301 PAX2 in human kidney malformations and disease.Pediatr Nephrol. 2012 Aug;27(8):1265-75. doi: 10.1007/s00467-011-2053-0. Epub 2011 Dec 3.
302 The ciliary gene RPGRIP1L is mutated in cerebello-oculo-renal syndrome (Joubert syndrome type B) and Meckel syndrome. Nat Genet. 2007 Jul;39(7):875-81. doi: 10.1038/ng2039. Epub 2007 Jun 10.
303 Progressive myoclonus epilepsy with nephropathy C1q due to SCARB2/LIMP-2 deficiency: clinical report of two siblings.Seizure. 2011 Nov;20(9):738-40. doi: 10.1016/j.seizure.2011.06.018. Epub 2011 Jul 22.
304 Mutations in the beta-subunit of the epithelial Na+ channel in patients with a cystic fibrosis-like syndrome.Hum Mol Genet. 2005 Nov 15;14(22):3493-8. doi: 10.1093/hmg/ddi374. Epub 2005 Oct 5.
305 A novel SCNN1G mutation in a PHA I infant patient correlates with nephropathy.Biochem Biophys Res Commun. 2019 Nov 5;519(2):415-421. doi: 10.1016/j.bbrc.2019.07.026. Epub 2019 Sep 12.
306 Analysis of coding variants identified from exome sequencing resources for association with diabetic and non-diabetic nephropathy in African Americans.Hum Genet. 2014 Jun;133(6):769-779. doi: 10.1007/s00439-013-1415-z. Epub 2014 Jan 3.
307 Contribution of the TTC21B gene to glomerular and cystic kidney diseases.Nephrol Dial Transplant. 2017 Jan 1;32(1):151-156. doi: 10.1093/ndt/gfv453.
308 The inhibition of Nrf2 accelerates renal lipid deposition through suppressing the ACSL1 expression in obesity-related nephropathy.Ren Fail. 2019 Nov;41(1):821-831. doi: 10.1080/0886022X.2019.1655450.
309 Wen-pi-tang-Hab-Wu-ling-san reduces ureteral obstructive renal fibrosis by the reduction of oxidative stress, inflammation, and TGF-beta/Smad2/3 signaling.Food Chem Toxicol. 2010 Feb;48(2):522-9. doi: 10.1016/j.fct.2009.11.006. Epub 2009 Nov 11.
310 Development of a novel cell-based assay to diagnose recurrent focal segmental glomerulosclerosis patients.Kidney Int. 2019 Mar;95(3):708-716. doi: 10.1016/j.kint.2018.10.030. Epub 2019 Jan 29.
311 ADAM19 expression in human nephrogenesis and renal disease: associations with clinical and structural deterioration.Kidney Int. 2006 Oct;70(7):1269-78. doi: 10.1038/sj.ki.5001753. Epub 2006 Aug 9.
312 Role of alpha-adducin DNA polymorphisms in the genetic predisposition to diabetic nephropathy.Nephrol Dial Transplant. 2004 Aug;19(8):2019-24. doi: 10.1093/ndt/gfh342. Epub 2004 Jun 8.
313 AGXT2 rs37369 polymorphism predicts the renal function in patients with chronic heart failure.Gene. 2017 Dec 30;637:145-151. doi: 10.1016/j.gene.2017.09.038. Epub 2017 Sep 21.
314 AHI1 is required for photoreceptor outer segment development and is a modifier for retinal degeneration in nephronophthisis.Nat Genet. 2010 Feb;42(2):175-80. doi: 10.1038/ng.519. Epub 2010 Jan 17.
315 Rapid, proteomic urine assay for monitoring progressive organ disease in Fabry disease.J Med Genet. 2020 Jan;57(1):38-47. doi: 10.1136/jmedgenet-2019-106030. Epub 2019 Sep 13.
316 Mutations in the gene that encodes the F-actin binding protein anillin cause FSGS. J Am Soc Nephrol. 2014 Sep;25(9):1991-2002. doi: 10.1681/ASN.2013090976. Epub 2014 Mar 27.
317 Characterizing renal involvement in Hermansky-Pudlak Syndrome in a zebrafish model.Sci Rep. 2019 Nov 27;9(1):17718. doi: 10.1038/s41598-019-54058-5.
318 Apolipoprotein C-I plays a role in the pathogenesis of glomerulosclerosis.J Pathol. 2017 Apr;241(5):589-599. doi: 10.1002/path.4859. Epub 2017 Feb 2.
319 Apolipoprotein M/sphingosine-1-phosphate: novel effects on lipids, inflammation and kidney biology.Curr Opin Lipidol. 2019 Jun;30(3):212-217. doi: 10.1097/MOL.0000000000000606.
320 Effects of cholecalciferol cholesterol emulsion on renal fibrosis and aquaporin 2 and 4 in mice with unilateral ureteral obstruction.Biomed Pharmacother. 2018 Jun;102:633-638. doi: 10.1016/j.biopha.2018.03.093. Epub 2018 Apr 5.
321 Progressive glomerular and tubular damage in sickle cell trait and sickle cell anemia mouse models.Transl Res. 2018 Jul;197:1-11. doi: 10.1016/j.trsl.2018.01.007. Epub 2018 Feb 2.
322 Preserved regulation of renal perfusion pressure by small and intermediate conductance KCa channels in hypertensive mice with or without renal failure.Pflugers Arch. 2015 Apr;467(4):817-31. doi: 10.1007/s00424-014-1542-y. Epub 2014 Jun 7.
323 Molecular basis of diseases caused by the mtDNA mutation m.8969G>A in the subunit a of ATP synthase.Biochim Biophys Acta Bioenerg. 2018 Aug;1859(8):602-611. doi: 10.1016/j.bbabio.2018.05.009. Epub 2018 May 18.
324 Superimposing a high-fat diet on Schistosoma mansoni infection affects renin-angiotensin system components in the mouse kidney.Rev Soc Bras Med Trop. 2019 Mar 7;52:e20180371. doi: 10.1590/0037-8682-0371-2018.
325 Bardet-Biedl Syndrome in rhesus macaques: A nonhuman primate model of retinitis pigmentosa.Exp Eye Res. 2019 Dec;189:107825. doi: 10.1016/j.exer.2019.107825. Epub 2019 Oct 4.
326 An impaired hepatic clock system effects lipid metabolism in rats with nephropathy.Int J Mol Med. 2018 Nov;42(5):2720-2736. doi: 10.3892/ijmm.2018.3833. Epub 2018 Aug 22.
327 Two mutations in human BICC1 resulting in Wnt pathway hyperactivity associated with cystic renal dysplasia.Hum Mutat. 2012 Jan;33(1):86-90. doi: 10.1002/humu.21610. Epub 2011 Oct 31.
328 Thrombocytopenia and kidney disease in mice with a mutation in the C1galt1 gene.Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16442-7. doi: 10.1073/pnas.0607872103. Epub 2006 Oct 24.
329 Efficacy and safety of tacrolimus and low-dose prednisone in Chinese children with steroid-resistant nephrotic syndrome.World J Pediatr. 2020 Apr;16(2):159-167. doi: 10.1007/s12519-019-00257-z. Epub 2019 May 2.
330 Assessment of biomarkers of drug-induced kidney injury in cynomolgus monkeys treated with a triple reuptake inhibitor.Toxicol Sci. 2011 Apr;120(2):269-83. doi: 10.1093/toxsci/kfr013. Epub 2011 Jan 22.
331 Caldesmon over-expression in type 1 diabetic nephropathy.J Diabetes Complications. 2011 Mar-Apr;25(2):114-21. doi: 10.1016/j.jdiacomp.2010.07.005. Epub 2010 Aug 30.
332 CaMK4 compromises podocyte function in autoimmune and nonautoimmune kidney disease.J Clin Invest. 2018 Aug 1;128(8):3445-3459. doi: 10.1172/JCI99507. Epub 2018 Jul 9.
333 Expression and effect of Calpain9 gene genetic polymorphism on slaughter indicators and intramuscular fat content in chickens.Poult Sci. 2018 Oct 1;97(10):3414-3420. doi: 10.3382/ps/pey232.
334 Novel finding of caveolin-2 in apical membranes of proximal tubule and first detection of caveolin-2 in urine: A promising biomarker of renal disease.J Cell Biochem. 2019 Apr;120(4):4966-4974. doi: 10.1002/jcb.27772. Epub 2018 Sep 30.
335 Prognostic value of visit-to-visit systolic blood pressure variability related to diabetic kidney disease among patients with type 2 diabetes.J Hypertens. 2019 Jul;37(7):1411-1418. doi: 10.1097/HJH.0000000000002038.
336 Regulation and bioactivity of the CCN family of genes and proteins in obesity and diabetes.J Cell Commun Signal. 2018 Mar;12(1):359-368. doi: 10.1007/s12079-018-0458-2. Epub 2018 Feb 6.
337 miR-939-5p decreases the enrichment of RNA polymerase II in the promoter region of CD2AP involved in nephrotic syndrome.J Cell Biochem. 2019 Jul;120(7):11366-11374. doi: 10.1002/jcb.28413. Epub 2019 Feb 12.
338 Involvement of the tubular ClC-type exchanger ClC-5 in glomeruli of human proteinuric nephropathies.PLoS One. 2012;7(9):e45605. doi: 10.1371/journal.pone.0045605. Epub 2012 Sep 24.
339 Down-regulation of magnesium transporting molecule, claudin-16, as a possible cause of hypermagnesiuria with the development of tubulo-interstitial nephropathy.Magnes Res. 2018 Feb 1;31(1):11-23. doi: 10.1684/mrh.2018.0434.
340 cMaf inducing protein inhibits cofilin? activity and alters podocyte cytoskeleton organization.Mol Med Rep. 2017 Oct;16(4):4955-4963. doi: 10.3892/mmr.2017.7156. Epub 2017 Aug 3.
341 Carnosinase concentration, activity, and CNDP1 genotype in patients with type 2 diabetes with and without nephropathy.Amino Acids. 2019 Apr;51(4):611-617. doi: 10.1007/s00726-018-02692-0. Epub 2019 Jan 4.
342 Purification, crystallization and preliminary crystallographic analysis of the CBS-domain pair of cyclin M2 (CNNM2).Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012 Oct 1;68(Pt 10):1198-203. doi: 10.1107/S1744309112035348. Epub 2012 Sep 26.
343 Gender differences and burden of chronic conditions: impact on quality of life among the elderly in Taiwan.Aging Clin Exp Res. 2019 Nov;31(11):1625-1633. doi: 10.1007/s40520-018-1099-2. Epub 2019 Jan 2.
344 Three Novel Heterozygous COL4A4 Mutations Result in Three Different Collagen Type IV Kidney Disease Phenotypes.Cytogenet Genome Res. 2018;154(1):30-36. doi: 10.1159/000486979. Epub 2018 Feb 15.
345 Collectins in urinary tract and kidney diseases.Int Urol Nephrol. 2018 Apr;50(4):695-703. doi: 10.1007/s11255-017-1728-2. Epub 2017 Oct 25.
346 A steroid-resistant nephrotic syndrome in an infant resulting from a consanguineous marriage with COQ2 and ARSB gene mutations: a case report.BMC Med Genet. 2019 Oct 28;20(1):165. doi: 10.1186/s12881-019-0898-4.
347 A novel ADCK4 mutation in a Chinese family with ADCK4-Associated glomerulopathy.Biochem Biophys Res Commun. 2018 Nov 30;506(3):444-449. doi: 10.1016/j.bbrc.2018.10.102. Epub 2018 Oct 21.
348 Vitamin B complex supplementation as a homocysteine-lowering therapy for early stage diabetic nephropathy in pediatric patients with type 1 diabetes: A randomized controlled trial.Clin Nutr. 2020 Jan;39(1):49-56. doi: 10.1016/j.clnu.2019.01.006. Epub 2019 Jan 17.
349 Association of genetic variants in the promoter region of genes encoding p22phox (CYBA) and glutamate cysteine ligase catalytic subunit (GCLC) and renal disease in patients with type 1 diabetes mellitus.BMC Med Genet. 2011 Sep 30;12:129. doi: 10.1186/1471-2350-12-129.
350 Getting a Notch closer to renal dysfunction: activated Notch suppresses expression of the adaptor protein Disabled-2 in tubular epithelial cells.FASEB J. 2019 Jan;33(1):821-832. doi: 10.1096/fj.201800392RR. Epub 2018 Jul 27.
351 Podocytes exhibit a specialized protein quality control employing derlin-2 in kidney disease.Am J Physiol Renal Physiol. 2018 Mar 1;314(3):F471-F482. doi: 10.1152/ajprenal.00691.2016. Epub 2017 Nov 22.
352 Nephrin-Binding Ephrin-B1 at the Slit Diaphragm Controls Podocyte Function through the JNK Pathway.J Am Soc Nephrol. 2018 May;29(5):1462-1474. doi: 10.1681/ASN.2017090993. Epub 2018 Mar 30.
353 The nephrology crystal ball: the medium-term future.Nephrol Dial Transplant. 2020 Feb 1;35(2):222-226. doi: 10.1093/ndt/gfz199.
354 Nephrocalcinosis in Amelogenesis Imperfecta Caused by the FAM20A Mutation.Nephron. 2018;139(2):189-196. doi: 10.1159/000486607. Epub 2018 Feb 13.
355 FAR2 is associated with kidney disease in mice and humans.Physiol Genomics. 2018 Aug 1;50(8):543-552. doi: 10.1152/physiolgenomics.00118.2017. Epub 2018 Apr 13.
356 A frame shift mutation in the fibrinogen A alpha chain gene in a kindred with renal amyloidosis.Blood. 1996 May 15;87(10):4197-203.
357 FLI1 Levels Impact CXCR3 Expression and Renal Infiltration of T Cells and Renal Glycosphingolipid Metabolism in the MRL/lpr Lupus Mouse Strain.J Immunol. 2015 Dec 15;195(12):5551-60. doi: 10.4049/jimmunol.1500961. Epub 2015 Nov 4.
358 Metabolic adaptability in hexavalent chromium-treated renal tissue: an in vivo study.Clin Kidney J. 2018 Apr;11(2):222-229. doi: 10.1093/ckj/sfx069. Epub 2017 Jul 27.
359 GDF11 induces kidney fibrosis, renal cell epithelial-to-mesenchymal transition, and kidney dysfunction and failure.Surgery. 2018 Aug;164(2):262-273. doi: 10.1016/j.surg.2018.03.008. Epub 2018 May 3.
360 SUMOylation Blocks the Ubiquitin-Mediated Degradation of the Nephronophthisis Gene Product Glis2/NPHP7.PLoS One. 2015 Jun 17;10(6):e0130275. doi: 10.1371/journal.pone.0130275. eCollection 2015.
361 Glycine N-methyltransferase inhibits aristolochic acid nephropathy by increasing CYP3A44 and decreasing NQO1 expression in female mouse hepatocytes.Sci Rep. 2018 May 3;8(1):6960. doi: 10.1038/s41598-018-22298-6.
362 Erratum to: Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials.Acta Diabetol. 2017 Nov;54(11):1069-1071. doi: 10.1007/s00592-017-1049-z.
363 Sex Differences in Glutathione Peroxidase Activity and Central Obesity in Patients with Type 2 Diabetes at High Risk of Cardio-Renal Disease.Antioxidants (Basel). 2019 Dec 7;8(12):629. doi: 10.3390/antiox8120629.
364 Guanylate Cyclase C: A Current Hot Target, from Physiology to Pathology.Curr Med Chem. 2018;25(16):1879-1908. doi: 10.2174/0929867325666171205150310.
365 Age-Related Expression of Human AT1R Variants and Associated Renal Dysfunction in Transgenic Mice.Am J Hypertens. 2018 Oct 15;31(11):1234-1242. doi: 10.1093/ajh/hpy121.
366 Understanding kidney injury molecule 1: a novel immune factor in kidney pathophysiology.Am J Transl Res. 2019 Mar 15;11(3):1219-1229. eCollection 2019.
367 Elevated hemoglobin glycation index identify non-diabetic individuals at increased risk of kidney dysfunction.Oncotarget. 2017 Jun 19;8(45):79576-79586. doi: 10.18632/oncotarget.18572. eCollection 2017 Oct 3.
368 HLA-E Polymorphism Determines Susceptibility to BK Virus Nephropathy after Living-Donor Kidney Transplant.Cells. 2019 Aug 7;8(8):847. doi: 10.3390/cells8080847.
369 Cranioectodermal Dysplasia, Sensenbrenner syndrome, is a ciliopathy caused by mutations in the IFT122 gene. Am J Hum Genet. 2010 Jun 11;86(6):949-56. doi: 10.1016/j.ajhg.2010.04.012. Epub 2010 May 20.
370 Polycystin-1 regulates the stability and ubiquitination of transcription factor Jade-1.Hum Mol Genet. 2012 Dec 15;21(26):5456-71. doi: 10.1093/hmg/dds391. Epub 2012 Sep 21.
371 COL4A5 and LAMA5 variants co-inherited in familial hematuria: digenic inheritance or genetic modifier effect?.BMC Nephrol. 2018 May 16;19(1):114. doi: 10.1186/s12882-018-0906-5.
372 De novo leukocyte chemotactic factor 2 amyloidosis in a pediatric renal allograft, 15years post-transplant.Pediatr Transplant. 2019 May;23(3):e13371. doi: 10.1111/petr.13371. Epub 2019 Feb 3.
373 Identifying genetic susceptibilities to diabetes-related complications among individuals at low risk of complications: An application of tree-structured survival analysis.Am J Epidemiol. 2006 Nov 1;164(9):862-72. doi: 10.1093/aje/kwj287. Epub 2006 Aug 23.
374 Acute kidney injury after pediatric cardiac surgery.Pediatr Neonatol. 2019 Feb;60(1):3-11. doi: 10.1016/j.pedneo.2018.03.007. Epub 2018 Mar 30.
375 MAGE genes in the kidney: identification of MAGED2 as upregulated during kidney injury and in stressed tubular cells.Nephrol Dial Transplant. 2019 Sep 1;34(9):1498-1507. doi: 10.1093/ndt/gfy367.
376 Weighted Gene Correlation Network Analysis (WGCNA) Detected Loss of MAGI2 Promotes Chronic Kidney Disease (CKD) by Podocyte Damage.Cell Physiol Biochem. 2018;51(1):244-261. doi: 10.1159/000495205. Epub 2018 Nov 16.
377 IP(3)R-Grp75-VDAC1-MCU calcium regulation axis antagonists protect podocytes from apoptosis and decrease proteinuria in an Adriamycin nephropathy rat model.BMC Nephrol. 2018 Jun 15;19(1):140. doi: 10.1186/s12882-018-0940-3.
378 Angiotensin receptor blocker vs ACE inhibitor effects on HDL functionality in patients on maintenance hemodialysis.Nutr Metab Cardiovasc Dis. 2018 Jun;28(6):582-591. doi: 10.1016/j.numecd.2018.02.020. Epub 2018 Mar 8.
379 The role of inflammasomes in kidney disease.Nat Rev Nephrol. 2019 Aug;15(8):501-520. doi: 10.1038/s41581-019-0158-z.
380 Analysis on difference in gastrointestinal hormone levels of patients with the history of diabetes and concurrent nephropathy and study on the role of liraglutide.Eur Rev Med Pharmacol Sci. 2017 Aug;21(15):3523-3529.
381 Kidney disease and organ transplantation in methylmalonic acidaemia.Pediatr Transplant. 2019 Jun;23(4):e13407. doi: 10.1111/petr.13407. Epub 2019 Apr 11.
382 The prevalence of depression and the association between depression and kidney function and health-related quality of life in elderly patients with chronic kidney disease: a multicenter cross-sectional study.Clin Interv Aging. 2019 May 15;14:905-913. doi: 10.2147/CIA.S203186. eCollection 2019.
383 Early-onset liver mtDNA depletion and late-onset proteinuric nephropathy in Mpv17 knockout mice.Hum Mol Genet. 2009 Jan 1;18(1):12-26. doi: 10.1093/hmg/ddn309. Epub 2008 Sep 24.
384 The association of metallothionein-4 gene polymorphism and renal function in long-term lead-exposed workers.Biol Trace Elem Res. 2010 Oct;137(1):55-62. doi: 10.1007/s12011-009-8564-x. Epub 2009 Nov 17.
385 Inactivation of max-interacting protein 1 induces renal cilia disassembly through reduction in levels of intraflagellar transport 20 in polycystic kidney.J Biol Chem. 2013 Mar 1;288(9):6488-97. doi: 10.1074/jbc.M112.413302. Epub 2013 Jan 13.
386 Successful treatment with humanized anti-interleukin-6 receptor antibody (tocilizumab) in a case of AA amyloidosis complicated by familial Mediterranean fever.Mod Rheumatol. 2016 Jul;26(4):610-3. doi: 10.3109/14397595.2014.908810. Epub 2015 Jan 25.
387 Promises and pitfalls of whole-exome sequencing exemplified by a nephrotic syndrome family.Mol Genet Genomics. 2020 Jan;295(1):135-142. doi: 10.1007/s00438-019-01609-0. Epub 2019 Sep 13.
388 Myocardin ablation in a cardiac-renal rat model.Sci Rep. 2019 Apr 10;9(1):5872. doi: 10.1038/s41598-019-42009-z.
389 Anti-Inflammatory Action of Sitagliptin and Linagliptin in Doxorubicin Nephropathy.Kidney Blood Press Res. 2018;43(3):987-999. doi: 10.1159/000490688. Epub 2018 Jun 15.
390 Adult onset tubulo-interstitial nephropathy in MT-ND5-related phenotypes.Clin Genet. 2020 Apr;97(4):628-633. doi: 10.1111/cge.13670. Epub 2020 Jan 9.
391 Dietary sodium modulates nephropathy in Nedd4-2-deficient mice.Cell Death Differ. 2020 Jun;27(6):1832-1843. doi: 10.1038/s41418-019-0468-5. Epub 2019 Dec 4.
392 Nox1 downregulators: A new class of therapeutics.Steroids. 2019 Dec;152:108494. doi: 10.1016/j.steroids.2019.108494. Epub 2019 Sep 10.
393 NADPH oxidase 5 and renal disease.Curr Opin Nephrol Hypertens. 2015 Jan;24(1):81-7. doi: 10.1097/MNH.0000000000000081.
394 NPHP4, a cilia-associated protein, negatively regulates the Hippo pathway.J Cell Biol. 2011 May 16;193(4):633-42. doi: 10.1083/jcb.201009069. Epub 2011 May 9.
395 Coding variants in nephrin (NPHS1) and susceptibility to nephropathy in African Americans.Clin J Am Soc Nephrol. 2014 Aug 7;9(8):1434-40. doi: 10.2215/CJN.00290114. Epub 2014 Jun 19.
396 Total Extracts of Abelmoschus manihot L. Attenuates Adriamycin-Induced Renal Tubule Injury via Suppression of ROS-ERK1/2-Mediated NLRP3 Inflammasome Activation.Front Pharmacol. 2019 May 28;10:567. doi: 10.3389/fphar.2019.00567. eCollection 2019.
397 Etiological analysis of graft dysfunction following living kidney transplantation: a report of 366 biopsies.Ren Fail. 2018 Nov;40(1):219-225. doi: 10.1080/0886022X.2018.1455592.
398 Renal Consequences of Gestational Diabetes Mellitus in Term Neonates: A Multidisciplinary Approach to the DOHaD Perspective in the Prevention and Early Recognition of Neonates of GDM Mothers at Risk of Hypertension and Chronic Renal Diseases in Later Life.J Clin Med. 2019 Mar 28;8(4):429. doi: 10.3390/jcm8040429.
399 Palladin is upregulated in kidney disease and contributes to epithelial cell migration after injury.Sci Rep. 2015 Jan 9;5:7695. doi: 10.1038/srep07695.
400 Neonatal asphyxia and renal failure as the presentation of non-inherited protein C deficiency.J Perinatol. 2013 Mar;33(3):239-41. doi: 10.1038/jp.2012.55.
401 Inhibiting cytosolic translation and autophagy improves health in mitochondrial disease.Hum Mol Genet. 2015 Sep 1;24(17):4829-47. doi: 10.1093/hmg/ddv207. Epub 2015 Jun 3.
402 Association of the salivary triggering receptor expressed on myeloid cells/its ligand peptidoglycan recognition protein 1 axis with oral inflammation in kidney disease.J Periodontol. 2018 Jan;89(1):117-129. doi: 10.1902/jop.2017.170218.
403 Prohibitin 2-mediated mitophagy attenuates renal tubular epithelial cells injury by regulating mitochondrial dysfunction and NLRP3 inflammasome activation.Am J Physiol Renal Physiol. 2019 Feb 1;316(2):F396-F407. doi: 10.1152/ajprenal.00420.2018. Epub 2018 Dec 12.
404 Caffeine Accelerates Cystic Kidney Disease in a Pkd1-Deficient Mouse Model.Cell Physiol Biochem. 2019;52(5):1061-1074. doi: 10.33594/000000072.
405 Polycystin 2: A calcium channel, channel partner, and regulator of calcium homeostasis in ADPKD.Cell Signal. 2020 Feb;66:109490. doi: 10.1016/j.cellsig.2019.109490. Epub 2019 Dec 2.
406 Reduced NOV/CCN3 Expression Limits Inflammation and Interstitial Renal Fibrosis after Obstructive Nephropathy in Mice.PLoS One. 2015 Sep 14;10(9):e0137876. doi: 10.1371/journal.pone.0137876. eCollection 2015.
407 Association of serum podocalyxin levels with peripheral arterial disease in patients with type 2 diabetes.J Diabetes Complications. 2019 Jul;33(7):495-499. doi: 10.1016/j.jdiacomp.2019.04.003. Epub 2019 Apr 14.
408 Proteasome subunit- type-6 protein is post-transcriptionally repressed by the microRNA-4490 in diabetic nephropathy.Biosci Rep. 2018 Oct 31;38(5):BSR20180815. doi: 10.1042/BSR20180815. Print 2018 Oct 31.
409 T2D and Depression Risk Gene Proteasome Modulator 9 is Linked to Insomnia.Sci Rep. 2015 Jul 13;5:12032. doi: 10.1038/srep12032.
410 Adrenomedullin-RAMP2 system suppresses ER stress-induced tubule cell death and is involved in kidney protection.PLoS One. 2014 Feb 5;9(2):e87667. doi: 10.1371/journal.pone.0087667. eCollection 2014.
411 Decreased glomerular filtration rate in patients with at least 5 years of type 2 diabetes in Ho Chi Minh City, Vietnam: Prevalence and associated factors.Prim Care Diabetes. 2020 Apr;14(2):173-180. doi: 10.1016/j.pcd.2019.08.003. Epub 2019 Sep 5.
412 Hypermethylations of RASAL1 and KLOTHO is associated with renal dysfunction in a Chinese population environmentally exposed to cadmium.Toxicol Appl Pharmacol. 2013 Aug 15;271(1):78-85. doi: 10.1016/j.taap.2013.04.025. Epub 2013 May 9.
413 Epigenetic regulation of RCAN1 expression in kidney disease and its role in podocyte injury.Kidney Int. 2018 Dec;94(6):1160-1176. doi: 10.1016/j.kint.2018.07.023. Epub 2018 Oct 23.
414 Renoprotective effects of sodium-glucose cotransporter-2 inhibitors and underlying mechanisms.Curr Opin Nephrol Hypertens. 2020 Jan;29(1):112-118. doi: 10.1097/MNH.0000000000000561.
415 Renal proteomic analysis of RGC-32 knockout mice reveals the potential mechanism of RGC-32 in regulating cell cycle.Am J Transl Res. 2018 Mar 15;10(3):847-856. eCollection 2018.
416 Regucalcin down-regulation in rat kidney tissue after treatment with nephrotoxicants.Toxicol Lett. 2008 Nov 10;182(1-3):84-90. doi: 10.1016/j.toxlet.2008.08.014. Epub 2008 Sep 2.
417 A putative regulatory polymorphism in PD-1 is associated with nephropathy in a population-based cohort of systemic lupus erythematosus patients.Lupus. 2004;13(7):510-6. doi: 10.1191/0961203303lu1052oa.
418 DBA2J db/db mice are susceptible to early albuminuria and glomerulosclerosis that correlate with systemic insulin resistance.Am J Physiol Renal Physiol. 2017 Feb 1;312(2):F312-F321. doi: 10.1152/ajprenal.00451.2016. Epub 2016 Nov 16.
419 A novel homozygous RRM2B missense mutation in association with severe mtDNA depletion.Neuromuscul Disord. 2009 Feb;19(2):147-50. doi: 10.1016/j.nmd.2008.11.014. Epub 2009 Jan 12.
420 News in pathophysiology, definition and classification of hepatorenal syndrome: A step beyond the International Club of Ascites (ICA) consensus document.J Hepatol. 2019 Oct;71(4):811-822. doi: 10.1016/j.jhep.2019.07.002. Epub 2019 Jul 11.
421 Targeted deletion of the AAA-ATPase Ruvbl1 in mice disrupts ciliary integrity and causes renal disease and hydrocephalus.Exp Mol Med. 2018 Jun 28;50(6):1-17. doi: 10.1038/s12276-018-0108-z.
422 Tissue-resident natural killer cells exacerbate tubulointerstitial fibrosis by activating transglutaminase 2 and syndecan-4 in a model of aristolochic acid-induced nephropathy.BMB Rep. 2019 Sep;52(9):554-559. doi: 10.5483/BMBRep.2019.52.9.193.
423 Mutational analysis of SDCCAG8 in Bardet-Biedl syndrome patients with renal involvement and absent polydactyly. Ophthalmic Genet. 2012 Sep;33(3):150-4. doi: 10.3109/13816810.2012.689411. Epub 2012 May 24.
424 The plasma biomarker soluble SIGLEC-1 is associated with the type I interferon transcriptional signature, ethnic background and renal disease in systemic lupus erythematosus.Arthritis Res Ther. 2018 Jul 27;20(1):152. doi: 10.1186/s13075-018-1649-1.
425 Misexpression of Six2 is associated with heritable frontonasal dysplasia and renal hypoplasia in 3H1 Br mice.Dev Dyn. 2008 Jul;237(7):1767-79. doi: 10.1002/dvdy.21587.
426 Recurrent atypical haemolytic uraemic syndrome post kidney transplant due to a CD46 mutation in the setting of SMARCAL1-mediated inherited kidney disease.Nephrology (Carlton). 2017 Feb;22 Suppl 1:11-14. doi: 10.1111/nep.12933.
427 Sorting Nexin 9 facilitates podocin endocytosis in the injured podocyte.Sci Rep. 2017 Mar 7;7:43921. doi: 10.1038/srep43921.
428 Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome.J Clin Invest. 2010 Mar;120(3):768-77. doi: 10.1172/JCI39569. Epub 2010 Feb 8.
429 SSBP1 mutations cause mtDNA depletion underlying a complex optic atrophy disorder.J Clin Invest. 2020 Jan 2;130(1):108-125. doi: 10.1172/JCI128514.
430 Direct acute tubular damage contributes to Shigatoxin-mediated kidney failure.J Pathol. 2014 Sep;234(1):120-33. doi: 10.1002/path.4388. Epub 2014 Jul 25.
431 SUMO4 163 G>A variation is associated with kidney disease in Indian subjects with type 2 diabetes.Mol Biol Rep. 2016 May;43(5):345-8. doi: 10.1007/s11033-016-3979-x. Epub 2016 Apr 7.
432 Synaptic vesicle protein 2B is expressed in podocyte, and its expression is altered in proteinuric glomeruli.J Am Soc Nephrol. 2006 Oct;17(10):2748-59. doi: 10.1681/ASN.2005121293. Epub 2006 Aug 30.
433 Proteinuric Kidney Diseases: A Podocyte's Slit Diaphragm and Cytoskeleton Approach.Front Med (Lausanne). 2018 Sep 11;5:221. doi: 10.3389/fmed.2018.00221. eCollection 2018.
434 Silencing of TRB3 Ameliorates Diabetic Tubule Interstitial Nephropathy via PI3K/AKT Signaling in Rats.Med Sci Monit. 2017 Jun 10;23:2816-2824. doi: 10.12659/msm.902581.
435 Proteomic analysis identifies transcriptional cofactors and homeobox transcription factors as TBX18 binding proteins.PLoS One. 2018 Aug 2;13(8):e0200964. doi: 10.1371/journal.pone.0200964. eCollection 2018.
436 TBX3, a downstream target of TGF-1, inhibits mesangial cell apoptosis.Exp Cell Res. 2014 Nov 1;328(2):340-50. doi: 10.1016/j.yexcr.2014.08.022. Epub 2014 Aug 23.
437 Inhibitory effect of pravastatin on transforming growth factor beta1-inducible gene h3 expression in a rat model of chronic cyclosporine nephropathy.Am J Nephrol. 2005 Nov-Dec;25(6):611-20. doi: 10.1159/000089905. Epub 2005 Nov 22.
438 Cellular and viral miRNA expression in polyomavirus BK infection.Transpl Infect Dis. 2019 Oct;21(5):e13159. doi: 10.1111/tid.13159. Epub 2019 Aug 29.
439 Amniotic fluid microvillar enzyme activity in fetal malformations.Clin Genet. 1990 Nov;38(5):340-5. doi: 10.1111/j.1399-0004.1990.tb03592.x.
440 Exonuclease TREX1 degrades double-stranded DNA to prevent spontaneous lupus-like inflammatory disease.Proc Natl Acad Sci U S A. 2015 Apr 21;112(16):5117-22. doi: 10.1073/pnas.1423804112. Epub 2015 Apr 6.
441 Knockdown of Add3 impairs the myogenic response of renal afferent arterioles and middle cerebral arteries.Am J Physiol Renal Physiol. 2017 Jun 1;312(6):F971-F981. doi: 10.1152/ajprenal.00529.2016. Epub 2016 Dec 7.
442 The genetic background difference between diabetic patients with and without nephropathy in a Taiwanese population by linkage disequilibrium mapping using 382 autosomal STR markers.Genet Test Mol Biomarkers. 2010 Jun;14(3):433-8. doi: 10.1089/gtmb.2009.0179.
443 Urinary AQP5 is independently associated with eGFR decline in patients with type 2 diabetes and nephropathy.Diabetes Res Clin Pract. 2019 Sep;155:107805. doi: 10.1016/j.diabres.2019.107805. Epub 2019 Aug 1.
444 ARF6 mediates nephrin tyrosine phosphorylation-induced podocyte cellular dynamics.PLoS One. 2017 Sep 7;12(9):e0184575. doi: 10.1371/journal.pone.0184575. eCollection 2017.
445 Genetic variants in Arhgef11 are associated with kidney injury in the Dahl salt-sensitive rat.Hypertension. 2012 Nov;60(5):1157-68. doi: 10.1161/HYPERTENSIONAHA.112.199240. Epub 2012 Sep 17.
446 Early growth response protein-1 upregulates long noncoding RNA Arid2-IR to promote extracellular matrix production in diabetic kidney disease.Am J Physiol Cell Physiol. 2019 Mar 1;316(3):C340-C352. doi: 10.1152/ajpcell.00167.2018. Epub 2018 Nov 21.
447 Bardet-Biedl syndrome: a study of the renal and cardiovascular phenotypes in a French cohort.Clin J Am Soc Nephrol. 2011 Jan;6(1):22-9. doi: 10.2215/CJN.03320410. Epub 2010 Sep 28.
448 Potential diagnostic biomarkers for IgA nephropathy: a comparative study pre- and post-tonsillectomy.Int Urol Nephrol. 2016 Nov;48(11):1855-1861. doi: 10.1007/s11255-016-1372-2. Epub 2016 Jul 27.
449 A disease-causing mutation illuminates the protein membrane topology of the kidney-expressed prohibitin homology (PHB) domain protein podocin.J Biol Chem. 2014 Apr 18;289(16):11262-11271. doi: 10.1074/jbc.M113.521773. Epub 2014 Mar 4.
450 Association of apoptosis inhibitor of macrophage (AIM) expression with urinary protein and kidney dysfunction.Clin Exp Nephrol. 2017 Feb;21(1):35-42. doi: 10.1007/s10157-016-1240-5. Epub 2016 Feb 5.
451 Cep97 and CP110 suppress a cilia assembly program.Cell. 2007 Aug 24;130(4):678-90. doi: 10.1016/j.cell.2007.06.027.
452 Claudins and mineral metabolism.Curr Opin Nephrol Hypertens. 2016 Jul;25(4):308-13. doi: 10.1097/MNH.0000000000000239.
453 The pattern recognition receptor, Mincle, is essential for maintaining the M1 macrophage phenotype in acute renal inflammation.Kidney Int. 2017 Mar;91(3):587-602. doi: 10.1016/j.kint.2016.10.020. Epub 2016 Dec 22.
454 Common variants in CNDP1 and CNDP2, and risk of nephropathy in type 2 diabetes.Diabetologia. 2011 Sep;54(9):2295-302. doi: 10.1007/s00125-011-2178-5. Epub 2011 May 15.
455 Chemical chaperone treatment reduces intracellular accumulation of mutant collagen IV and ameliorates the cellular phenotype of a COL4A2 mutation that causes haemorrhagic stroke.Hum Mol Genet. 2014 Jan 15;23(2):283-92. doi: 10.1093/hmg/ddt418. Epub 2013 Sep 2.
456 Hypertension-related, calcium-regulated gene (HCaRG/COMMD5) and kidney diseases: HCaRG accelerates tubular repair.J Nephrol. 2014 Aug;27(4):351-60. doi: 10.1007/s40620-014-0054-3. Epub 2014 Feb 11.
457 Coro2b, a podocyte protein downregulated in human diabetic nephropathy, is involved in the development of protamine sulphate-induced foot process effacement.Sci Rep. 2019 Jun 20;9(1):8888. doi: 10.1038/s41598-019-45303-y.
458 A novel mutation MT-COIII m.9267G>C and MT-COI m.5913G>A mutation in mitochondrial genes in a Tunisian family with maternally inherited diabetes and deafness (MIDD) associated with severe nephropathy.Biochem Biophys Res Commun. 2015 Apr 10;459(3):353-60. doi: 10.1016/j.bbrc.2015.01.151. Epub 2015 Feb 19.
459 Expanding the phenotype of CRB2 mutations-A new ciliopathy syndrome?.Clin Genet. 2016 Dec;90(6):540-544. doi: 10.1111/cge.12764. Epub 2016 May 2.
460 Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems.Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3227-45. doi: 10.1152/ajpheart.00998.2007. Epub 2007 Oct 12.
461 Nuclear relocation of the nephrin and CD2AP-binding protein dendrin promotes apoptosis of podocytes.Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10134-9. doi: 10.1073/pnas.0700917104. Epub 2007 May 30.
462 Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1.J Clin Endocrinol Metab. 2009 Nov;94(11):4483-91. doi: 10.1210/jc.2009-0089. Epub 2009 Oct 9.
463 NADPH oxidase 4 promotes cisplatin-induced acute kidney injury via ROS-mediated programmed cell death and inflammation.Lab Invest. 2018 Jan;98(1):63-78. doi: 10.1038/labinvest.2017.120. Epub 2017 Nov 6.
464 DNase II polymorphisms associated with risk of renal disorder among systemic lupus erythematosus patients.J Hum Genet. 2005;50(3):107-111. doi: 10.1007/s10038-004-0227-3. Epub 2005 Feb 19.
465 Alternatively spliced isoforms of fibronectin in immune-mediated glomerulosclerosis: the role of TGFbeta and IL-4.J Pathol. 2004 Nov;204(3):248-57. doi: 10.1002/path.1653.
466 LY333531, a PKC inhibitor, attenuates glomerular endothelial cell apoptosis in the early stage of mouse diabetic nephropathy via down-regulating swiprosin-1.Acta Pharmacol Sin. 2017 Jul;38(7):1009-1023. doi: 10.1038/aps.2016.172. Epub 2017 Apr 17.
467 The FERM protein EPB41L5 regulates actomyosin contractility and focal adhesion formation to maintain the kidney filtration barrier.Proc Natl Acad Sci U S A. 2017 Jun 6;114(23):E4621-E4630. doi: 10.1073/pnas.1617004114. Epub 2017 May 23.
468 Multi-organ abnormalities and mTORC1 activation in zebrafish model of multiple acyl-CoA dehydrogenase deficiency.PLoS Genet. 2013 Jun;9(6):e1003563. doi: 10.1371/journal.pgen.1003563. Epub 2013 Jun 13.
469 Phenotypic consequences in a Japanese family having branchio-oto-renal syndrome with a novel frameshift mutation in the gene EYA1.Acta Otolaryngol. 2007 Jan;127(1):98-104. doi: 10.1080/00016480500527185.
470 Molecular analysis of SV-40-CAL, a new slow growing SV-40 strain from the kidney of a caged New World monkey with fatal renal disease.Virus Genes. 2004 Oct;29(2):183-90. doi: 10.1023/B:VIRU.0000036378.42136.7c.
471 Kindlin-2 mediates activation of TGF-/Smad signaling and renal fibrosis.J Am Soc Nephrol. 2013 Sep;24(9):1387-98. doi: 10.1681/ASN.2012101041. Epub 2013 May 30.
472 Modulation of Glucokinase Regulatory Protein: A Double-Edged Sword?.Trends Mol Med. 2015 Oct;21(10):583-594. doi: 10.1016/j.molmed.2015.08.004.
473 Apolipoprotein M: Research progress, regulation and metabolic functions (Review).Mol Med Rep. 2015 Aug;12(2):1617-24. doi: 10.3892/mmr.2015.3658. Epub 2015 Apr 22.
474 Hedgehog Interacting Protein Promotes Fibrosis and Apoptosis in Glomerular Endothelial Cells in Murine Diabetes.Sci Rep. 2018 Apr 13;8(1):5958. doi: 10.1038/s41598-018-24220-6.
475 Hemicentin 1 influences podocyte dynamic changes in glomerular diseases.Am J Physiol Renal Physiol. 2018 Jun 1;314(6):F1154-F1165. doi: 10.1152/ajprenal.00198.2017. Epub 2018 Feb 28.
476 Serum urate gene associations with incident gout, measured in the Framingham Heart Study, are modified by renal disease and not by body mass index.Rheumatol Int. 2016 Feb;36(2):263-70. doi: 10.1007/s00296-015-3364-4. Epub 2015 Oct 1.
477 Study of the association between ITPKC genetic polymorphisms and calcium nephrolithiasis.Biomed Res Int. 2014;2014:397826. doi: 10.1155/2014/397826. Epub 2014 Mar 3.
478 Dominant-Negative Effect of a Missense Variant in the TASK-2 (KCNK5) K+ Channel Associated with Balkan Endemic Nephropathy.PLoS One. 2016 May 26;11(5):e0156456. doi: 10.1371/journal.pone.0156456. eCollection 2016.
479 A syndrome comprising childhood-onset glomerular kidney disease and ocular abnormalities with progressive loss of vision is caused by mutated LAMB2.Nephrol Dial Transplant. 2006 Nov;21(11):3283-6. doi: 10.1093/ndt/gfl463. Epub 2006 Aug 18.
480 PINCH-1 promotes tubular epithelial-to-mesenchymal transition by interacting with integrin-linked kinase.J Am Soc Nephrol. 2007 Sep;18(9):2534-43. doi: 10.1681/ASN.2007030315. Epub 2007 Jul 26.
481 Genome-wide association study for renal traits in the Framingham Heart and Atherosclerosis Risk in Communities Studies.BMC Med Genet. 2008 Jun 3;9:49. doi: 10.1186/1471-2350-9-49.
482 Clinical and histological findings of autosomal dominant renal-limited disease with LMX1B mutation.Nephrology (Carlton). 2016 Sep;21(9):765-73. doi: 10.1111/nep.12666.
483 Association between haptoglobin gene variants and diabetic nephropathy: haptoglobin polymorphism in nephropathy susceptibility.Nephron Exp Nephrol. 2007;105(3):e75-9. doi: 10.1159/000098563. Epub 2007 Jan 12.
484 Protein Z is reduced in chronic kidney disease and not elevated in patients on haemodialysis.Blood Coagul Fibrinolysis. 2008 Jan;19(1):23-5. doi: 10.1097/MBC.0b013e3282f09df2.
485 Genetic variation at the ACE gene is associated with persistent microalbuminuria and severe nephropathy in type 1 diabetes: the DCCT/EDIC Genetics Study.Diabetes. 2005 Apr;54(4):1238-44. doi: 10.2337/diabetes.54.4.1238.
486 Renalase, a new renal hormone: its role in health and disease.Curr Opin Nephrol Hypertens. 2007 Jul;16(4):373-8. doi: 10.1097/MNH.0b013e3281bd8877.
487 Knockdown of RTN1A attenuates ER stress and kidney injury in albumin overload-induced nephropathy.Am J Physiol Renal Physiol. 2016 Mar 1;310(5):F409-15. doi: 10.1152/ajprenal.00485.2015. Epub 2016 Jan 6.
488 Nephropathy in Townes-Brocks syndrome (SALL1 mutation): imaging and pathological findings in adulthood.Nephrol Dial Transplant. 2009 Apr;24(4):1341-5. doi: 10.1093/ndt/gfp014. Epub 2009 Feb 9.
489 A novel podocyte gene, semaphorin 3G, protects glomerular podocyte from lipopolysaccharide-induced inflammation.Sci Rep. 2016 May 16;6:25955. doi: 10.1038/srep25955.
490 Genome-wide meta-analysis for severe diabetic retinopathy.Hum Mol Genet. 2011 Jun 15;20(12):2472-81. doi: 10.1093/hmg/ddr121. Epub 2011 Mar 26.
491 Kidney disease in primary anti-phospholipid antibody syndrome.Rheumatology (Oxford). 2017 Jul 1;56(7):1069-1080. doi: 10.1093/rheumatology/kew307.
492 Rituximab protects podocytes and exerts anti-proteinuric effects in rat adriamycin-induced nephropathy independent of B-lymphocytes.Nephrology (Carlton). 2017 Jan;22(1):49-57. doi: 10.1111/nep.12737.
493 Smad ubiquitination regulatory factor-2 in the fibrotic kidney: regulation, target specificity, and functional implication.Am J Physiol Renal Physiol. 2008 May;294(5):F1076-83. doi: 10.1152/ajprenal.00323.2007. Epub 2008 Mar 19.
494 Serum and urinary SOD3 in patients with type 2 diabetes: comparison with early chronic kidney disease patients and association with development of diabetic nephropathy.Am J Physiol Renal Physiol. 2019 Jan 1;316(1):F32-F41. doi: 10.1152/ajprenal.00401.2017. Epub 2018 Oct 10.
495 SORCS1 contributes to the development of renal disease in rats and humans.Physiol Genomics. 2013 Aug 15;45(16):720-8. doi: 10.1152/physiolgenomics.00089.2013. Epub 2013 Jun 18.
496 Proteinuria and baseline renal function predict mortality and renal outcomes after sirolimus therapy in liver transplantation recipients.BMC Gastroenterol. 2017 Apr 20;17(1):58. doi: 10.1186/s12876-017-0611-z.
497 Electron microscopy in kidney research: seeing is believing.Ultrastruct Pathol. 2013 Oct;37(5):340-5. doi: 10.3109/01913123.2013.810689. Epub 2013 Jul 22.